Chronic nephritic syndrome

N14_CHRONEPHROPATH

nephritis: Inflammation of renal tissue. [ NCIT:P378 ]

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N03# Hospital discharge: ICD-9 — 582 Hospital discharge: ICD-8 — 582 Cause of death: ICD-10 — N03# Cause of death: ICD-9 — 582 Cause of death: ICD-8 — 582 2 out of 7 registries used, show all original rules.	1654
4. Check minimum number of events None	1654
5. Include endpoints None	1654
6. Filter based on genotype QC (FinnGen only)	1470

Control definitions (FinnGen only)

Control exclude: N14_GLOMERULAR

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: N00-N08
Name in latin: Syndroma nephriticum chronicum

NAME	N14_CHRONEPHROPATH
CONTROL_EXCLUDE	N14_GLOMERULAR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N03
HD_ICD_9	582
HD_ICD_8	582
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N03
COD_ICD_9	582
COD_ICD_8	582
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Chronic nephritic syndrome based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Membranous nephropathy

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11680	4699	6744
Only index persons	7799	3375	4424
Unadjusted period prevalence (%)
Whole population	0.17	0.13	0.19
Only index persons	0.15	0.12	0.17
Median age at first event (years)
Whole population	50.03	48.25	51.03
Only index persons	43.31	41.25	44.89

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1470	615	855
Unadjusted period prevalence (%)	0.32	0.22	0.39
Median age at first event (years)	43.87	38.46	47.76

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1530: Matched controls
15300

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

114.7

321.1

164

196

Kela drug reimbursment

Paricalcitol and cinacalcet

172.4

314.6

155

H02AB04

ATC

methylprednisolone; systemic

7.4

308.4

611

1259

B03XA01

ATC

erythropoietin; parenteral

65.6

307.7

185

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

157.8

307.7

251

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

207.4

307.7

376

A12AA04

ATC

calcium carbonate; oral

126.6

307.7

416

N18.8

ICD-10 Finland

Other chronic renal failure

55.5

307.7

372

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

22.0

307.7

583

416

137

Kela drug reimbursment

Uraemia requiring dialysis

243.4

307.7

295

Z49.0

ICD-10 Finland

Preparatory care for dialysis

105.2

307.7

217

V03AE01

ATC

polystyrene sulfonate; oral

58.8

307.7

239

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

68.5

307.7

276

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

210.2

307.7

317

L04AD01

ATC

ciclosporin; systemic

44.7

307.7

317

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

107.4

307.7

534

B05DA

ATC

Isotonic solutions

233.4

307.7

220

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

+∞

307.7

584

L04AA01

ATC

[U] ciclosporin

53.6

307.7

248

L04AD02

ATC

tacrolimus; systemic

70.6

307.7

249

B05DB

ATC

Hypertonic solutions

207.8

307.7

199

TK800

NOMESCO Finland

Hemodialysis

48.5

307.7

370

100

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

300.5

307.7

272

L04AA06

ATC

mycophenolic acid; systemic

68.6

307.7

424

A11CC03

ATC

alfacalcidol; systemic

73.8

307.7

483

127

Kela drug reimbursment

Transplant complication

86.5

307.7

417

Z49.1

ICD-10 Finland

Extracorporeal dialysis

75.7

307.7

309

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

3893.6

307.7

323

B03XA02

ATC

darbepoetin alfa; parenteral

43.6

307.7

330

N18.0

ICD-10 Finland

End-stage renal disease

117.1

307.7

246

Z94.0

ICD-10 Finland

Kidney transplant status

223.7

307.7

422

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

131.0

307.7

279

Z49.2

ICD-10 Finland

Other dialysis

169.7

307.7

193

R80

ICD-10 Finland

Isolated proteinuria

99.9

307.7

200

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

123.9

307.7

575

V03AE02

ATC

sevelamer; oral

167.4

305.8

151

C03CA01

ATC

furosemide; systemic

6.6

296.3

949

3052

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

113.4

281.6

144

205

Kela drug reimbursment

Chronic hypertension

6.1

278.7

861

2650

KA1AE

NOMESCO Finland

Kidney ultrasound examination

17.7

272.2

233

154

H05BX01

ATC

cinacalcet; oral

88.4

260.0

137

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

9.3

254.4

351

477

M04AA01

ATC

allopurinol; systemic

6.4

252.8

558

1252

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

+∞

252.3

235

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

6.5

251.4

547

1210

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

9.5

236.2

314

406

N03.3

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

+∞

235.7

220

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

127.8

233.4

118

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

430.0

227.9

223

L04AX01

ATC

azathioprine; systemic

11.5

227.0

254

260

58209

ICD-8 Finland

Chronic nephritis, Unspecified

+∞

223.6

209

C09AA02

ATC

enalapril; systemic

5.4

220.6

643

1820

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

27.8

219.1

151

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

46.9

218.6

129

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

58.0

200.5

113

321

Kela drug reimbursment

Paricalcitol and cinacalcet

62.3

197.8

110

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

79.6

194.6

104

C02AC05

ATC

moxonidine; oral

8.9

180.1

245

322

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

8.7

180.0

248

331

N03.1

ICD-10 Finland

Chronic nephritic syndrome, focal and segmental glomerular lesions

+∞

174.4

164

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

54.4

170.1

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

6.7

155.6

277

488

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

29.3

154.7

104

N03.2

ICD-10 Finland

Chronic nephritic syndrome, diffuse membranous glomerulonephritis

+∞

151.6

143

N03.0

ICD-10 Finland

Chronic nephritic syndrome, minor glomerular abnormality

+∞

147.3

139

TPX10

NOMESCO Finland

Implantation of vascular injection port

10.1

147.1

176

195

N19

ICD-10 Finland

Unspecified kidney failure

9.1

146.8

191

236

N08.2

ICD-10 Finland

Glomerular disorders in blood diseases and disorders involving the immune mechanism

+∞

145.2

137

D89.80

ICD-10 Finland

Immunoglobulin A (IgA) deposits in organisms

+∞

144.1

136

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

1468.5

139.8

134

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

161.7

127.5

133

C08CA01

ATC

amlodipine; oral

3.5

125.5

876

4244

5828A

ICD-9 Finland

Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]

+∞

123.6

117

C08CA02

ATC

felodipine; oral

5.0

123.1

312

752

C02EA02, ,

ATC

7.8

122.9

181

258

C07AG02

ATC

carvedilol; oral

6.2

122.8

231

426

KBV00

NOMESCO Finland

Insertion of stent into ureter

35.2

121.6

TK810

NOMESCO Finland

Hemofiltration

32.8

116.0

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

+∞

112.9

107

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

5.7

112.8

234

472

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

205.1

111.1

114

3025

Kela drug reimbursment

Calcium carbonate

33.8

110.8

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.7

110.0

298

754

K65.0

ICD-10 Finland

Acute peritonitis

19.3

106.1

C02CA01

ATC

prazosin; oral

13.6

105.0

100

TK820

NOMESCO Finland

Peritoneal dialysis

193.5

104.8

108

M10.9

ICD-10 Finland

Gout, unspecified

4.8

103.8

266

642

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.5

102.9

179

304

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

59.2

101.5

V03AE03

ATC

lanthanum carbonate; oral

154.3

96.3

101

WW200

NOMESCO Finland

Immunization

8.6

94.0

125

157

ZX120

NOMESCO Finland

Intravenous

4.3

93.8

282

768

58200

ICD-8 Finland

Chronic nephritis, Cum uraemia

+∞

93.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.9

93.1

328

1001

M10.3

ICD-10 Finland

Gout due to impairment of renal function

32.8

92.9

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

480.8

92.3

U14

ICPC

Kidney symptom/complaint

12.7

91.6

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

9.6

91.5

111

124

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.9

89.8

674

3238

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

32.9

88.3

N04.0

ICD-10 Finland

Nephrotic syndrome, minor glomerular abnormality

+∞

87.3

N04.2

ICD-10 Finland

Nephrotic syndrome, diffuse membranous glomerulonephritis

+∞

87.3

212

Kela drug reimbursment

Gout

9.7

85.1

102

112

3AC01, ,

NOMESCO Finland

18.0

84.7

L01AA01

ATC

cyclophosphamide; systemic

36.6

84.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

5.9

83.9

160

296

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

80.6

946

5631

A12AA12

ATC

[U] calcium acetate

797.6

78.0

N03.5

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangiocapillary glomerulonephritis

+∞

77.8

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

396.6

76.5

RD210, ,

NOMESCO Finland

10.8

76.2

7151

FHL

Kidney transplantation

270.3

76.2

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

8.8

76.1

118

C08CA13

ATC

lercanidipine; oral

3.3

75.8

352

1272

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

24.3

75.5

5829A

ICD-9 Finland

Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,EI NEFR SDR]

+∞

74.6

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.7

74.6

272

842

H26.3

ICD-10 Finland

Drug-induced cataract

19.7

73.0

M01AE01

ATC

ibuprofen; systemic, rectal

0.4

72.4

908

12173

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

131.3

70.6

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

129.5

69.5

78930

ICD-8 Finland

Abnormal urinary constituents of unspecified cause, Haematuria

19.0

69.3

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.5

68.7

117

193

C08CA03

ATC

isradipine; systemic

13.5

68.5

A41.9

ICD-10 Finland

Sepsis, unspecified

5.8

68.0

131

244

R50.9

ICD-10 Finland

Fever, unspecified

3.0

67.3

369

1460

C07AB02

ATC

metoprolol; systemic

2.8

67.1

431

1857

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

11.6

67.0

C10AA05

ATC

atorvastatin; oral

2.5

66.1

819

4838

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

122.2

65.4

R31

ICD-10 Finland

Unspecified haematuria

3.3

65.3

287

996

I15.0

ICD-10 Finland

Renovascular hypertension

25.7

64.3

WX202

NOMESCO Finland

Supraclavicular plexus blockade

9.5

62.9

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.1

62.3

304

1121

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

8.0

62.0

113

ZXD05

NOMESCO Finland

Urgent procedure

2.5

61.7

596

3118

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

26.0

61.6

N05.9

ICD-10 Finland

Unspecified nephritic syndrome, unspecified

622.2

61.2

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

23.8

61.0

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

6.4

60.9

105

175

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.4

60.8

246

809

Z2446

NOMESCO Finland

Social worker

4.0

60.2

184

500

C10AA04

ATC

fluvastatin; oral

3.6

59.3

223

699

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

58.3

391

1708

RS220, ,

NOMESCO Finland

10.4

57.8

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

5.8

56.5

108

199

R4190

NOMESCO Finland

Nutritional therapy

4.8

56.5

133

295

R4110

NOMESCO Finland

Physiotherapy

2.4

56.0

550

2873

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

55.8

461

2224

C09CA01

ATC

losartan; oral

2.5

55.8

522

2667

A12BA01

ATC

potassium chloride; oral

5.1

55.8

123

258

58199

ICD-8 Finland

Nephrotic syndrome

+∞

55.6

J01MA12

ATC

levofloxacin; systemic

2.6

55.3

404

1837

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.7

55.0

378

1667

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

14.9

54.7

58399

ICD-8 Finland

Nephritis, unqualified

+∞

54.5

C02DE10, ,

ATC

11.4

53.1

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

3.1

52.1

252

918

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

51.8

506

2621

7910X

ICD-9 Finland

Nonspecific findings on examination of urine, Proteinuria[PROTEINURIA NUD]

182.9

51.2

N18

ICD-10 Finland

Chronic kidney disease

9.7

50.0

B01AB10

ATC

tinzaparin; parenteral

3.0

49.6

255

960

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

12.0

49.1

ZX108

NOMESCO Finland

Inhalation

12.7

48.9

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.6

48.7

121

280

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.9

47.5

108

232

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.5

47.3

120

282

ZXE20

NOMESCO Finland

More than three and less than five hours

2.7

47.3

298

1249

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

168.6

47.1

J01FF01

ATC

clindamycin; systemic

2.3

46.8

518

2808

XPX08

NOMESCO Finland

Intraoperative flow measurement

10.3

46.2

C08CA05

ATC

nifedipine; systemic

3.7

45.0

150

431

L01BB01, ,

ATC

101.2

45.0

B07.9

ICD-10 Finland

Verruca simplex

4.7

44.7

108

244

H05BX02

ATC

paricalcitol; systemic

+∞

44.0

ZXA00

NOMESCO Finland

Right side

2.2

43.5

486

2632

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

10.5

43.3

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

43.2

510

2822

E87.5

ICD-10 Finland

Hyperkalaemia

6.8

42.8

104

WX610

NOMESCO Finland

Patient controlled analgesia

13.7

42.6

KBV10

NOMESCO Finland

Removal of stent from ureter

11.9

42.2

M05BA04

ATC

alendronic acid; oral

3.3

41.6

169

552

JN3AD

NOMESCO Finland

Abdominal CT examination

2.6

41.3

278

1198

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

69.1

41.3

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.7

41.0

246

1000

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

40.6

623

3793

WX203

NOMESCO Finland

Infraclavicular plexus blockade

6.0

40.3

124

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

407.9

40.3

78900

ICD-8 Finland

Abnormal urinary constituents of unspecified cause, Albuminuria

77.3

40.1

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

210.5

40.0

J01MA02

ATC

ciprofloxacin; systemic

2.0

39.8

680

4300

N06.9

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, unspecified

+∞

39.8

WW500

NOMESCO Finland

Blood transfusion

4.2

39.3

109

274

Z3231

NOMESCO Finland

Registered nurse

2.1

39.1

490

2757

TK824

NOMESCO Finland

Replacement of peritoneal dialysis catheter extension tube

205.2

39.0

L04AA05

ATC

[U] tacrolimus

140.3

38.9

Z3226

NOMESCO Finland

Physiotherapist

2.3

38.6

344

1682

A46

ICD-10 Finland

Erysipelas

2.4

38.1

306

1429

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

37.9

521

3030

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.5

37.7

143

ZXC50

NOMESCO Finland

Cryotherapy

4.7

37.7

197

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

37.7

225

911

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.9

37.6

202

774

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.2

37.6

157

521

RJ411, ,

NOMESCO Finland

13.8

37.5

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

194.7

36.9

I10

ICD-10 Finland

Essential (primary) hypertension

2.0

36.9

1009

7454

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.3

36.7

235

N17.8

ICD-10 Finland

Other acute renal failure

7.7

36.6

5820A

ICD-9 Finland

Chronic glomerulonephritis, With lesion of proliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA PROLIF,EI NEFR SDR]

+∞

36.6

M10.0

ICD-10 Finland

Idiopathic gout

4.1

36.5

106

276

H02AB06

ATC

prednisolone; systemic

2.0

36.2

796

5438

A10AC01

ATC

insulin (human); parenteral

3.1

36.2

167

587

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

4.7

36.1

192

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

189.4

35.9

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

189.4

35.9

5828B

ICD-9 Finland

Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,NEFR SDR]

+∞

35.6

58099

ICD-8 Finland

Acute nephritis

+∞

35.6

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

9.2

35.2

ZXA05

NOMESCO Finland

Left side

2.1

35.0

431

2391

C02DE02, ,

ATC

7.2

34.9

A10AB05

ATC

insulin aspart; parenteral

3.0

34.7

169

612

5839X

ICD-9 Finland

Nephritis and nephropathy, not specified as acute or chronic, With unspecified pathological lesion in kidney

+∞

34.5

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

8.1

34.2

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.9

34.2

160

N02AX02

ATC

tramadol; systemic, rectal

1.9

33.9

737

4980

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

33.6

441

2501

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

3.1

33.5

148

507

N03.7

ICD-10 Finland

Chronic nephritic syndrome, diffuse crescentic glomerulonephritis

+∞

33.5

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.8

33.4

108

303

J01MA14

ATC

moxifloxacin; systemic

2.8

33.4

191

754

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.6

32.9

116

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

38.3

32.6

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.2

32.4

354

1868

N04.3

ICD-10 Finland

Nephrotic syndrome, diffuse mesangial proliferative glomerulonephritis

+∞

32.4

A02BC01

ATC

omeprazole; systemic

2.0

32.3

461

2688

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

32.2

340

1771

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.4

32.1

120

371

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.3

31.6

126

405

C09CA06

ATC

candesartan; oral

2.0

31.4

424

2421

C08DB01

ATC

diltiazem; oral

3.5

31.3

115

351

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

3.6

31.1

109

323

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

319.2

30.9

N00.9

ICD-10 Finland

Acute nephritic syndrome, Unspecified

+∞

30.3

B01AA03

ATC

warfarin; systemic

2.1

30.2

337

1788

C07AB07

ATC

bisoprolol; oral

1.9

30.2

797

5658

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

11.7

30.1

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.3

30.0

120

387

UKC02

NOMESCO Finland

Cystoscopy

2.2

29.9

310

1599

C10AA01

ATC

simvastatin; oral

1.8

29.3

676

4589

5602

FHL

Internal fistula (eg Cimino)

+∞

29.3

N25.0

ICD-10 Finland

Renal osteodystrophy

41.0

29.1

4059B

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]

152.9

28.7

D69.0

ICD-10 Finland

Allergic purpura

10.9

28.7

M01AH05

ATC

etoricoxib; oral

0.5

28.7

531

7623

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.1

28.5

207

A10BK01

ATC

dapagliflozin; oral

2.7

28.4

171

691

N03.4

ICD-10 Finland

Chronic nephritic syndrome, diffuse endocapillary proliferative glomerulonephritis

+∞

28.2

5819X

ICD-9 Finland

Nephrotic syndrome with unspecified pathological lesion in kidney

+∞

28.2

TQW80

NOMESCO Finland

Local dermatologic skincare

4.5

27.8

159

K65.8

ICD-10 Finland

Other peritonitis

48.1

27.5

N00.2

ICD-10 Finland

Acute nephritic syndrome, Diffuse membranous glomerulonephritis

+∞

27.2

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

+∞

27.2

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

76.6

26.8

TJW99

NOMESCO Finland

Other minor procedure in gastrointestinal endoscopy

42.1

26.8

I50.9

ICD-10 Finland

Heart failure, unspecified

2.2

26.8

256

1273

U88

ICPC

Glomerulonephritis/nephrosis

98.5

26.7

Z99.2

ICD-10 Finland

Dependence on renal dialysis

142.5

26.7

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

26.3

206

941

M10

ICD-10 Finland

Gout

3.1

26.2

112

375

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

+∞

26.1

N082, D898,

ICD-10 Finland

+∞

26.1

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.8

26.1

221

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

264.9

25.8

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.7

25.5

234

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

25.5

217

1028

40399

ICD-8 Finland

Hypertensive renal disease

50.9

25.3

N04.89

ICD-10 Finland

Nephrotic syndrome, other

+∞

25.1

K65.9

ICD-10 Finland

Peritonitis, unspecified

59.1

25.1

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.9

24.8

196

ZXE00

NOMESCO Finland

One hour or less

1.8

24.8

610

4165

KAS40

NOMESCO Finland

Excision of transplanted kidney

254.1

24.7

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

4.6

24.7

136

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

43.6

24.6

WX002

NOMESCO Finland

Sedation and analgesia

2.0

24.3

325

1828

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

35.1

24.3

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

+∞

24.0

N04.5

ICD-10 Finland

Nephrotic syndrome, diffuse mesangiocapillary glomerulonephritis

+∞

24.0

N00.0

ICD-10 Finland

Acute nephritic syndrome, Minor glomerular abnormality

+∞

24.0

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.9

24.0

187

Kela drug reimbursment

MPA

88.2

23.7

5850B

ICD-9 Finland

Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]

243.7

23.7

40199

ICD-8 Finland

Essential benign hypertension

5.6

23.4

C09AA01

ATC

captopril; oral

5.3

23.2

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

8.1

23.1

K06.18

ICD-10 Finland

Another gingival hyperplasia

20.4

23.1

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

23.0

650

4587

M13.9

ICD-10 Finland

Arthritis, unspecified

2.6

23.0

147

611

JAL10

NOMESCO Finland

Laparotomy and removal of foreign body

66.0

22.9

BBA50

NOMESCO Finland

Total parathyroidectomy

84.8

22.7

WX204

NOMESCO Finland

Axillary plexus blockaced

3.4

22.6

253

5997A

ICD-9 Finland

Other disorders of urethra and urinary tract, Haematuria

21.0

22.6

RS221, ,

NOMESCO Finland

5.8

22.5

204

Kela drug reimbursment

Leukemia lymphatica

4.0

22.3

165

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

52.8

22.1

C02EA01, ,

ATC

7.2

22.1

WX892

NOMESCO Finland

Monitored bed care

2.5

22.0

152

654

H02AB07

ATC

prednisone; oral

2.1

22.0

229

1173

JN4AD

NOMESCO Finland

Body CT examination

2.1

21.9

220

1110

B04AB02, ,

ATC

4.5

21.8

120

GD2SN

NOMESCO Finland

Lung ventilation SPECT

8.2

21.8

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.5

21.6

147

628

RS222, ,

NOMESCO Finland

6.3

21.5

B01AB04

ATC

dalteparin; parenteral

3.0

21.3

337

A07AA09

ATC

vancomycin; oral

5.5

21.3

UJF32

NOMESCO Finland

Coloscopy

1.8

21.1

418

2652

Z2221

NOMESCO Finland

Medical doctor

1.8

21.1

427

2728

A02BC02

ATC

pantoprazole; systemic

1.7

20.9

1044

8490

N08.2*D69.0

ICD-10 Finland

Glomerular disorders in Henoch(-Schönlein) purpura

+∞

20.9

A10BH05

ATC

linagliptin; oral

2.9

20.7

102

370

Z3229

NOMESCO Finland

Other healthcare associate professional

2.4

20.7

152

673

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.7

20.7

119

469

6119

FHL

Other measure in this category

212.8

20.6

C09BA02

ATC

enalapril and diuretics; systemic

2.4

20.6

144

623

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

20.6

570

3969

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.3

20.2

163

751

XQ848

NOMESCO Finland

Dermatological photography

3.6

20.1

197

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

19.1

20.0

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.0

19.9

317

D89.8

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

+∞

19.8

5829B

ICD-9 Finland

Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,NEFR SDR]

+∞

19.8

5821B

ICD-9 Finland

Chronic glomerulonephritis, With lesion of membranous glomerulonephritis[GLOMERULONEPHRITIS CHRONICA MEMBRANACEA,NEFR SDR]

+∞

19.8

N06.1

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, focal and segmental glomerular lesions

+∞

19.8

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

19.7

134

572

1XC02, ,

NOMESCO Finland

8.2

19.7

J01CF02

ATC

cloxacillin; systemic

4.3

19.6

122

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.1

19.6

194

973

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.5

19.5

110

L57.0

ICD-10 Finland

Actinic keratosis

2.2

19.4

185

914

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.2

19.3

128

C10AA02

ATC

lovastatin; oral

3.2

19.3

253

5AB14, ,

NOMESCO Finland

46.6

19.2

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

19.2

241

1318

ED1AA

NOMESCO Finland

Mandibular X-ray examination

7.3

19.1

WX402

NOMESCO Finland

General anaesthesia

1.8

18.9

361

2257

N08.2*D89.82

ICD-10 Finland

Nepropathy caused by deposition of the light chain of the immunoglobulins

+∞

18.8

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

+∞

18.8

N05.8

ICD-10 Finland

Unspecified nephritic syndrome, other

+∞

18.8

WW400

NOMESCO Finland

Plasmaferesis

70.8

18.7

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

7.1

18.7

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

3.9

18.6

145

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

192.3

18.6

M31.3

ICD-10 Finland

Wegener granulomatosis

25.4

18.2

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.9

18.2

300

TQW99

NOMESCO Finland

Other minor procedure on skin

2.7

17.9

382

C10AX09

ATC

ezetimibe; oral

1.8

17.8

292

1740

A10AB01

ATC

insulin (human); parenteral

3.3

17.7

219

A10AE04

ATC

insulin glargine; parenteral

2.1

17.6

170

843

H26.02

ICD-10 Finland

Presenil cataract

3.6

17.6

170

J01DB01

ATC

cefalexin; oral

1.8

17.5

1240

10779

J01DA01

ATC

[U] cefalexin

1.6

17.4

916

7374

WZC30

NOMESCO Finland

Teaching

1.9

17.3

272

1599

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.5

17.1

N05CF01

ATC

zopiclone; oral

1.6

17.1

483

3345

C02DE04, ,

ATC

3.9

17.1

131

I77.0

ICD-10 Finland

Arteriovenous fistula, acquired

31.9

17.0

C03AA03

ATC

hydrochlorothiazide; oral

2.3

17.0

143

670

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.8

17.0

136

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

3.8

16.9

141

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.9

16.9

132

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

22.1

16.9

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.5

16.9

165

S97

ICPC

Chronic ulcer skin

2.4

16.8

120

524

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

+∞

16.7

7155

FHL

Exploration of the graft

+∞

16.7

5821A

ICD-9 Finland

Chronic glomerulonephritis, With lesion of membranous glomerulonephritis[GLOMERULONEPHRITIS CHRONICA MEMBRANACEA,EI NEFR SDR]

+∞

16.7

Y0699

ICD-8 Finland

Examination of the urinary and genital organs, Urinary organs. Does not include urine tests to determine endocrine and metabolic disorders (Y 00.99)

7.4

16.6

5900A

ICD-9 Finland

Infections of kidney, Chronic pyelonephritis

171.8

16.5

C09AA03

ATC

lisinopril; oral

2.8

16.4

323

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

16.1

451

3110

H3603, E103,

ICD-10 Finland

11.8

16.1

C10AA03

ATC

pravastatin; oral

2.3

16.0

125

568

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

12.4

15.9

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

6.7

15.8

H26.2

ICD-10 Finland

Complicated cataract

5.1

15.8

J01CA04

ATC

amoxicillin; systemic

1.7

15.7

1207

10511

PBU99

NOMESCO Finland

Other repair after previous reconstruction of arteries of upper extremity

+∞

15.6

N06.0

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, minor glomerular abnormality

+∞

15.6

N02.9

ICD-10 Finland

Recurrent and persistent haematuria, unspecified

+∞

15.6

D638, N188,

ICD-10 Finland

+∞

15.6

RJ530, ,

NOMESCO Finland

+∞

15.6

N03

ICD-10 Finland

Chronic nephritic syndrome

+∞

15.6

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

+∞

15.6

N06.2

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, diffuse membranous glomerulonephritis

+∞

15.6

N06.3

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, diffuse mesangial proliferative glomerulonephritis

+∞

15.6

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

15.5

548

3987

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

6.3

15.5

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

38.5

15.4

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

15.3

109

476

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.4

15.2

110

483

E0000UV, ,

ATC

1.6

15.2

597

4447

H02AB09

ATC

hydrocortisone; systemic

3.7

15.2

133

B01AC04

ATC

clopidogrel; oral

1.8

15.1

268

1628

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

5.7

15.1

J01FA06

ATC

roxithromycin; oral

1.6

15.1

571

4214

XQ845

NOMESCO Finland

Dermatoscopy

3.9

15.1

115

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

5.0

15.0

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

10.9

15.0

TGC00

NOMESCO Finland

Bronchial lavation

3.3

15.0

173

NHQ40

NOMESCO Finland

Amputation of toe

4.2

15.0

306

Kela drug reimbursment

Erythropoietin and darbepoetin

16.7

14.8

E21.2

ICD-10 Finland

Other hyperparathyroidism

16.7

14.8

XF612

NOMESCO Finland

Measurement of central venous pressure

18.6

14.7

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

6.2

14.7

SPAT1255

SPAT

Intravenous administration of medicine

2.3

14.7

115

523

D638, N180,

ICD-10 Finland

+∞

14.6

B05D

ATC

PERITONEAL DIALYTICS

+∞

14.6

N08.2*D57.8

ICD-10 Finland

Glomerular disorders in sickle-cell disorders

+∞

14.6

N083, E102,

ICD-10 Finland

+∞

14.6

PC6DE, ,

NOMESCO Finland

+∞

14.6

N00.3

ICD-10 Finland

Acute nephritic syndrome, Diffuse mesangial proliferative glomerulonephritis

+∞

14.6

K06.10

ICD-10 Finland

Gingival fibromatosis

80.9

14.6

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

4.1

14.5

9968A

ICD-9 Finland

Complications peculiar to certain specified procedures, Complications of transplanted organ

151.4

14.5

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

5.9

14.5

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.1

14.4

198

59000

ICD-8 Finland

Infections of kidney, Pyelonephritis chronica

15.5

14.4

288

Kela drug reimbursment

Febuxostat

12.7

14.4

RJ410, ,

NOMESCO Finland

17.2

14.3

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.1

14.3

WX890

NOMESCO Finland

Intesive care monitoring

6.2

14.2

XF602

NOMESCO Finland

Bloodpressure monitoring

5.2

14.1

J01MA06

ATC

norfloxacin; oral

1.9

14.1

186

1030

RJ421, ,

NOMESCO Finland

14.6

14.1

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.7

14.1

121

C09CA07

ATC

telmisartan; oral

2.2

14.0

126

606

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

5.9

14.0

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

14.0

117

547

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.2

14.0

R60.0

ICD-10 Finland

Localized oedema

1.9

14.0

198

1122

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.5

13.9

141

M04AA03

ATC

febuxostat; oral

12.8

13.9

RJ210, ,

NOMESCO Finland

30.3

13.9

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.4

13.9

101

445

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

13.8

246

1494

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

13.7

563

4210

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

13.6

103

462

4039A

ICD-9 Finland

Hypertensive renal disease, Unspecified

+∞

13.6

TKA00

NOMESCO Finland

Needle biopsy of kidney or pelvis of kidney

+∞

13.6

5813A

ICD-9 Finland

Nephrotic syndrome, With lesion of minimal change glomerulonephritis

+∞

13.6

N05.3

ICD-10 Finland

Unspecified nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

+∞

13.6

5820B

ICD-9 Finland

Chronic glomerulonephritis, With lesion of proliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA PROLIF,NEFR SDR]

+∞

13.6

N00.8

ICD-10 Finland

Acute nephritic syndrome, Other

+∞

13.6

SPAT1262

SPAT

Handing over of treatment supplies

1.7

13.5

260

1614

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

13.5

136

684

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.0

13.5

PB1AT

NOMESCO Finland

Upper extremity artery PTA

141.2

13.5

D638, N189,

ICD-10 Finland

141.2

13.5

TK823

NOMESCO Finland

Peritoneal permeability analysis

141.2

13.5

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

16.4

13.5

R4180

NOMESCO Finland

Podiatric therapy

4.2

13.5

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

13.4

151

791

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.1

13.4

M01AB05

ATC

diclofenac; systemic, rectal

0.7

13.3

657

8119

B34.9

ICD-10 Finland

Viral infection, unspecified

3.2

13.3

171

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

9.8

13.2

A41.8

ICD-10 Finland

Other specified sepsis

3.7

13.2

117

O12.1

ICD-10 Finland

Gestational proteinuria

15.2

13.1

A10AA01, ,

ATC

3.3

13.1

152

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

13.0

107

496

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

4.2

13.0

H3603, E113,

ICD-10 Finland

6.2

12.9

EBA10

NOMESCO Finland

Operative extraction of tooth

1.9

12.9

189

1082

RJ120, ,

NOMESCO Finland

50.4

12.9

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

50.4

12.9

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

12.8

272

1732

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.7

12.8

235

1439

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.2

12.7

114

548

I50.0

ICD-10 Finland

Congestive heart failure

2.1

12.6

120

590

ZX197, ,

NOMESCO Finland

70.5

12.6

2503B

ICD-9 Finland

Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]

70.5

12.6

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

12.6

128

646

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.1

12.5

177

PG5ST

NOMESCO Finland

Endovascular thrombolysis of arterio-venous shunt for dialysis with radiological guidance

+∞

12.5

PB1BT

NOMESCO Finland

Extensive upper extremity artery PTA

+∞

12.5

N0830, E102,

ICD-10 Finland

+∞

12.5

N08.3

ICD-10 Finland

Glomerular disorders in diabetes mellitus

+∞

12.5

7101

FHL

Needle biopsy in the operating room

+∞

12.5

H15.1

ICD-10 Finland

Episcleritis

4.3

12.5

ZZA00

NOMESCO Finland

Split skin graft

2.9

12.5

199

5604

FHL

Vascular preparation or cannulation in the operating room

20.2

12.5

5850A

ICD-9 Finland

Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA SINE URAEMIA]

131.0

12.5

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

12.4

301

1985

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.6

12.4

268

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

11.7

12.3

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.5

12.3

118

C08CA10

ATC

nilvadipine; oral

3.7

12.2

104

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

12.2

146

782

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

12.2

501

3727

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.1

12.1

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

6.1

12.1

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

4.2

12.1

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

8.7

12.0

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

8.7

12.0

N43.3

ICD-10 Finland

Hydrocele, unspecified

3.2

12.0

155

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.5

12.0

115

K05.31

ICD-10 Finland

Periodontitis pronounced

1.8

12.0

180

1037

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

5.7

12.0

R11

ICD-10 Finland

Nausea and vomiting

2.0

11.9

133

694

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.7

11.9

4059A

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA RENOVASCULARIS]

47.0

11.9

GD1UN

NOMESCO Finland

Lung circulation SPECT

9.0

11.8

A10AA02, ,

ATC

2.8

11.7

206

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

11.7

426

Z94.4

ICD-10 Finland

Liver transplant status

12.6

11.6

KA2DE, ,

NOMESCO Finland

65.5

11.6

NFA20

NOMESCO Finland

Exploration of hip joint or femur

65.5

11.6

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.4

11.6

351

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.6

11.5

254

SDA05

NOMESCO Finland

Very demanding periodontal treatment

2.1

11.5

115

577

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

11.5

117

591

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

11.5

411

2961

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

11.5

331

2272

NFA10

NOMESCO Finland

Biopsy of soft tissue or joint of hip and thigh, percutaneous

+∞

11.5

N02.8

ICD-10 Finland

Recurrent and persistent haematuria, other

+∞

11.5

5822A

ICD-9 Finland

Chronic glomerulonephritis, With lesion of membranoproliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA MESANGIOCAP,EI NEFR SDR]

+∞

11.5

N03.6

ICD-10 Finland

Chronic nephritic syndrome, dense deposit disease

+∞

11.5

305

Kela drug reimbursment

MPA

+∞

11.5

7158

FHL

Graft removal

+∞

11.5

TPX15

NOMESCO Finland

Removal of vascular injection port

13.7

11.5

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

120.9

11.4

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

11.3

315

2143

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.9

11.3

188

AA1AD

NOMESCO Finland

CT of head and brain

1.5

11.2

424

3088

ZXA10

NOMESCO Finland

Bilateral

1.7

11.2

254

1643

RJ190, ,

NOMESCO Finland

20.2

11.1

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

11.1

289

E86

ICD-10 Finland

Volume depletion

3.0

11.1

163

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.5

11.0

WX730

NOMESCO Finland

Conventional respirator

3.9

11.0

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

10.9

110

554

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.3

10.8

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

10.6

10.8

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

8.9

10.8

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.9

10.7

59328

ICD-8 Finland

Other diseases of kidney and ureter, Morbi renis alii

60.4

10.6

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

60.4

10.6

M31.7

ICD-10 Finland

Microscopic polyangiitis

60.4

10.6

J94.8

ICD-10 Finland

Other specified pleural conditions

4.0

10.6

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

10.5

459

A10BH02

ATC

vildagliptin; oral

3.5

10.5

106

B01AB05

ATC

enoxaparin; parenteral

1.5

10.4

437

3242

N08.30

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

110.8

10.4

5809A

ICD-9 Finland

Acute glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS ACUTA NUD,EI NEFR SDR]

+∞

10.4

N04

ICD-10 Finland

Nephrotic syndrome

+∞

10.4

N06.8

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, other

+∞

10.4

N05.0

ICD-10 Finland

Unspecified nephritic syndrome, minor glomerular abnormality

+∞

10.4

N04.80

ICD-10 Finland

Congenital nephrotic syndrome of the Finnish type

+∞

10.4

N082, D899,

ICD-10 Finland

+∞

10.4

N00.5

ICD-10 Finland

Acute nephritic syndrome, Diffuse mesangiocapillary glomerulonephritis

+∞

10.4

5824A

ICD-9 Finland

Chronic glomerulonephritis, With lesion of rapidly progressive glomerulonephritis[CRESCENT GLOMERULONEPHRITIS ,EI NEFR SDR]

+∞

10.4

58299, ,

ICD-8 Finland

+∞

10.4

N0832, E102,

ICD-10 Finland

+∞

10.4

N04.4

ICD-10 Finland

Nephrotic syndrome, diffuse endocapillary proliferative glomerulonephritis

+∞

10.4

N08.2*D59.3

ICD-10 Finland

Glomerular disorders in haemolytic-uraemic syndrome

+∞

10.4

WX213

NOMESCO Finland

Lower leg blockade

5.5

10.4

KFD20

NOMESCO Finland

Excision of hydrocele of testis

3.6

10.4

T92

ICPC

Gout

3.0

10.4

153

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

32.8

10.3

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

10.3

190

1161

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

3.5

10.3

102

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.3

10.3

122

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

10.3

164

961

K05.30

ICD-10 Finland

Periodontitis complex

1.7

10.3

225

1440

Z50.1

ICD-10 Finland

Other physical therapy

2.2

10.3

396

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

10.3

338

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

10.2

294

Y83.0

ICD-10 Finland

Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

23.5

10.2

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

10.2

101

505

N04BC05

ATC

pramipexole; oral

2.0

10.2

110

568

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

13.2

10.2

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.0

10.2

144

SCD02

NOMESCO Finland

Removal of biofilm and/or supragingival calculus

8.0

10.1

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.6

10.1

235

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

10.1

105

535

N43.0

ICD-10 Finland

Encysted hydrocele

4.4

10.1

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

11.4

10.1

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

10.0

257

1711

RJ420, ,

NOMESCO Finland

9.2

10.0

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

10.1

10.0

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

10.0

276

1869

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

4.1

10.0

L04AA10

ATC

[U] sirolimus

40.3

10.0

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

10.0

116

615

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

9.9

349

A10AD05

ATC

insulin aspart; parenteral

3.5

9.9

100

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.0

9.9

102

518

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

4.3

9.9

TK830

NOMESCO Finland

Ultrafiltration

26.2

9.8

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

26.2

9.8

M08.2

ICD-10 Finland

Juvenile arthritis with systemic onset

26.2

9.8

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

4.4

9.8

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

20.2

9.8

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.9

9.8

349

Kela drug reimbursment

Febuxostat

10.7

9.8

C07AB03

ATC

atenolol; systemic

2.2

9.8

411

RJ521, ,

NOMESCO Finland

55.4

9.7

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

9.6

626

5029

J01CA08

ATC

pivmecillinam; oral

1.5

9.6

442

3333

KAC10

NOMESCO Finland

Total nephrectomy with capsule

5.1

9.6

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

4.5

9.6

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.8

9.5

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

15.1

9.5

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

9.5

331

2359

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

9.4

154

909

Q87.80

ICD-10 Finland

Alport syndrome

100.6

9.4

D89.9

ICD-10 Finland

Disorder involving the immune mechanism, unspecified

100.6

9.4

RS321, ,

NOMESCO Finland

100.6

9.4

RJ129, ,

NOMESCO Finland

100.6

9.4

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

9.4

151

887

RJ425, ,

NOMESCO Finland

30.2

9.4

TKA02

NOMESCO Finland

Needle biopsy of transplanted kidney

+∞

9.4

N082, Z940,

ICD-10 Finland

+∞

9.4

PH1AT

NOMESCO Finland

Endovascular extension of superior vena cava and of arteries of upper extremity

+∞

9.4

N08.2*D89.1

ICD-10 Finland

Glomerular disorders in cryoglobulinaemia

+∞

9.4

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.2

9.4

371

WVA20

NOMESCO Finland

Medicine administration

2.6

9.4

208

ZXC15

NOMESCO Finland

Use of photodynamic technique

3.8

9.3

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

4.0

9.3

B02.9

ICD-10 Finland

Zoster without complication

2.0

9.3

103

536

A10AE05

ATC

insulin detemir; parenteral

2.2

9.3

392

B01AF02

ATC

apixaban; oral

1.7

9.3

195

1233

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

9.3

358

2603

E000006, ,

ATC

2.1

9.3

467

R06.0

ICD-10 Finland

Dyspnoea

1.5

9.3

389

2876

K05.11

ICD-10 Finland

Gingivitis (chronic) hyperplastic

10.7

9.3

A02BA02

ATC

ranitidine; systemic

1.6

9.3

264

1799

U70

ICPC

Pyelonephritis/pyelitis

3.9

9.2

WX882

NOMESCO Finland

High dependency care

2.8

9.2

169

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.6

9.2

204

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

9.2

350

2539

A10AB04

ATC

insulin lispro; parenteral

2.6

9.1

199

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

9.1

443

3368

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

9.1

152

2436

H3600, E113,

ICD-10 Finland

4.4

9.1

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

4.0

9.1

QDH05

NOMESCO Finland

Correction of deformity of toe nail

11.5

9.1

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

9.0

386

2863

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

9.0

228

1511

I50.1

ICD-10 Finland

Left ventricular failure

2.1

9.0

378

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

2.0

8.9

460

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.9

8.9

150

J05AB11

ATC

valaciclovir; oral

1.6

8.9

201

1297

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

8.9

142

834

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

8.8

407

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.7

8.8

179

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.3

8.8

308

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

8.7

8.8

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.2

8.7

QCA50

NOMESCO Finland

Cryotherapy of skin of upper limb

50.3

8.7

5672A

ICD-9 Finland

Peritonitis, Other suppurative peritonitis[PERITONITIS SUPPURATIVA DIFFUSA]

50.3

8.7

A01AB09

ATC

miconazole; local oral

1.9

8.7

115

637

C07FB02

ATC

metoprolol and felodipine; systemic

2.7

8.7

175

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.6

8.6

193

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

4.0

8.6

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.3

8.6

273

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

8.3

8.6

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

10.1

8.5

Z94.1

ICD-10 Finland

Heart transplant status

10.1

8.5

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

3.4

8.5

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

8.5

331

2408

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

20.1

8.5

KAS96

NOMESCO Finland

Other transplantation of kidney or related procedure

90.5

8.4

PB1ST

NOMESCO Finland

Thrombolysis of upper extremity artery

90.5

8.4

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.9

8.4

104

563

M01AC06

ATC

meloxicam; systemic, rectal

0.7

8.4

278

3823

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

4.3

8.4

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.2

8.4

106

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.2

8.4

101

T89

ICPC

Diabetes insulin dependent

2.3

8.4

289

C07AG01

ATC

labetalol; systemic

4.5

8.4

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.4

8.4

D07AB08

ATC

desonide; topical

1.7

8.4

149

902

N08.4*E85.9

ICD-10 Finland

Glomerular disorders in amyloidosis

+∞

8.3

N05.2

ICD-10 Finland

Unspecified nephritic syndrome, diffuse membranous glomerulonephritis

+∞

8.3

C02DC01

ATC

minoxidil; oral

+∞

8.3

N08.5*M30.0

ICD-10 Finland

Glomerular disorders in polyarteritis nodosa

+∞

8.3

N0830, E112,

ICD-10 Finland

+∞

8.3

PBU81

NOMESCO Finland

Thrombectomy in arteriovenous fistula from artery of upper extremity

+∞

8.3

N082, I151,

ICD-10 Finland

+∞

8.3

N08.5*M31.0

ICD-10 Finland

Glomerular disorders in Goodpasture's syndrome

+∞

8.3

5822B

ICD-9 Finland

Chronic glomerulonephritis, With lesion of membranoproliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA MESANGIOCAP,NEFR SDR]

+∞

8.3

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

8.6

8.3

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

8.3

156

SAA04

NOMESCO Finland

Special examination of mouth

2.1

8.3

397

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

3.9

8.3

N02BE01

ATC

paracetamol; systemic, rectal

1.5

8.2

1300

12025

R04.0

ICD-10 Finland

Epistaxis

1.8

8.2

115

648

HA1AA

NOMESCO Finland

X-ray mammography

1.9

8.2

510

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.4

8.2

235

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.7

8.2

163

J01DA06

ATC

[U] cefuroxime

1.6

8.1

192

1250

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

33.5

8.1

JA3FT

NOMESCO Finland

Exchange abdominal catheter with radiological guidance

33.5

8.1

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

8.0

102

557

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.9

8.0

125

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.8

8.0

112

631

C01DA14

ATC

isosorbide mononitrate; oral

1.6

8.0

214

1436

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.2

8.0

KA3EB

NOMESCO Finland

Antegrade pyelography

7.3

8.0

3626

FHL

Extracapsular cataract surgery and implantation of an artificial lens

4.3

7.9

5901A

ICD-9 Finland

Infections of kidney, Acute pyelonephritis

4.5

7.9

D68.8

ICD-10 Finland

Other specified coagulation defects

4.0

7.9

K01.0

ICD-10 Finland

Embedded teeth

3.5

7.8

C03BA11

ATC

indapamide; oral

2.7

7.8

161

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

3.3

7.8

E000001, ,

ATC

1.5

7.8

252

1762

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.4

7.8

234

ECA35

NOMESCO Finland

Complicated excision of lesion of gingiva

9.5

7.8

ZY010

NOMESCO Finland

Hospital outpatient

2.1

7.7

366

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.2

7.7

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

7.7

216

RJ412, ,

NOMESCO Finland

15.1

7.7

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

45.2

7.7

8070/3-C44.6

ICD-O-3

Squamous cell carcinoma, NOS, of skin of upper limb and shoulder

45.2

7.7

SPAT1164

SPAT

Haemodialysis

45.2

7.7

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

7.7

132

790

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.2

7.7

J01DA09

ATC

[U] cefadroxil

1.4

7.7

353

2644

TFP20

NOMESCO Finland

Cardiodefibrillation

1.8

7.7

109

617

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

4.5

7.7

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.6

7.6

163

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

2.4

7.6

205

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

7.6

249

C09CA03

ATC

valsartan; oral

1.7

7.6

138

839

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.1

7.6

355

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

8.1

7.6

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

8.1

7.6

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

8.1

7.6

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

11.9

7.6

PB1AE

NOMESCO Finland

Ultrasound examination of arteries of upper extremity

25.1

7.6

RJ512, ,

NOMESCO Finland

25.1

7.6

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.1

7.5

J04AB02

ATC

rifampicin; systemic

3.8

7.5

L73.8

ICD-10 Finland

Other specified follicular disorders

3.8

7.5

A07AA02

ATC

nystatin; oral

2.0

7.5

398

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

4.3

7.5

RJ124, ,

NOMESCO Finland

80.5

7.4

PG5YT

NOMESCO Finland

Stenting of arteriovenous fistula

80.5

7.4

N11.0

ICD-10 Finland

Nonobstructive reflux-associated chronic pyelonephritis

80.5

7.4

PH1BC

NOMESCO Finland

Extensive ultrasound examination of upper extremity veins

80.5

7.4

G63.8*N18.8

ICD-10 Finland

Uraemic neuropathy

80.5

7.4

TJA30

NOMESCO Finland

Peritoneal dialysis

80.5

7.4

N30.0

ICD-10 Finland

Acute cystitis

1.6

7.4

198

1327

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

7.4

187

1237

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

7.4

407

PE1AT

NOMESCO Finland

Femoral artery PTA

3.5

7.4

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

3.4

7.4

N18.2

ICD-10 Finland

Chronic kidney disease, stage 2

7.7

7.4

RJ414, ,

NOMESCO Finland

13.4

7.4

G04CA02

ATC

tamsulosin; oral

1.4

7.4

377

2877

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.8

7.4

ECA30

NOMESCO Finland

Excision of lesion of gingiva

4.0

7.4

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

8.4

7.3

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.6

7.3

N05CD07

ATC

temazepam; oral

1.6

7.3

155

983

5818X

ICD-9 Finland

Nephrotic syndrome, With other specified pathological lesion in kidney

+∞

7.3

XQ834

NOMESCO Finland

Exercise challenge test

+∞

7.3

4464A

ICD-9 Finland

Polyarteritis nodosa and allied conditions, Wegener's granulomatosis

+∞

7.3

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.2

7.3

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.9

7.3

PG1CG

NOMESCO Finland

Extensive MRI examination of vasculature with high intensity magnet not elsewhere classified

15.8

7.2

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.3

7.2

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.7

7.2

AN1

Coronary angiography

1.6

7.2

153

971

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

4.0

7.2

N15.9

ICD-10 Finland

Renal tubulo-interstitial disease, unspecified

30.2

7.1

3XA02, ,

NOMESCO Finland

30.2

7.1

A12AA06

ATC

calcium lactate gluconate; oral

30.2

7.1

E87.7

ICD-10 Finland

Fluid overload

20.1

7.1

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

20.1

7.1

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.2

7.1

64090

ICD-8 Finland

Artificial termination of pregnancy performed for medical reasons, Woman's illness or physical defect (medicines. Cause)

4.1

7.1

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

7.0

151

960

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

7.0

142

889

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

10.1

7.0

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.1

7.0

NFQ20

NOMESCO Finland

Amputation of femur

4.2

7.0

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

4.2

7.0

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

7.0

126

765

K92.1

ICD-10 Finland

Melaena

2.0

7.0

402

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

7.0

388

E000002, ,

ATC

1.7

6.9

136

845

SCA02

NOMESCO Finland

Preventive oral health care

1.7

6.9

127

775

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.4

6.9

203

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.0

6.8

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.8

6.8

120

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

6.8

123

749

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

2.8

6.8

115

R22.7

ICD-10 Finland

Localized swelling, mass and lump, multiple sites

40.2

6.8

E83.50

ICD-10 Finland

Hypercalcemia

3.7

6.8

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

4.3

6.8

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.1

6.8

4029B

ICD-9 Finland

Hypertensive heart disease, Unspecified[CUM DECOMPENSATIONE CORDIS (WHO III)]

16.8

6.7

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

2.6

6.7

144

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

6.7

429

PWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system

7.2

6.7

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.7

6.7

133

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

6.7

423

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.6

6.6

145

J01CF05

ATC

flucloxacillin; systemic

1.8

6.6

103

600

C07AB08

ATC

celiprolol; oral

2.5

6.6

169

WX722

NOMESCO Finland

PEEP

2.0

6.6

374

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.7

6.6

122

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

6.6

278

XF402

NOMESCO Finland

ECG with work load test

1.6

6.6

144

919

WNF00

NOMESCO Finland

Infection source and contact determination

7.8

6.6

EB1WA, ,

NOMESCO Finland

5.5

6.6

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.9

6.6

J01CF01

ATC

dicloxacillin; systemic

5.9

6.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

6.6

171

1138

N02AA05

ATC

oxycodone; systemic

1.5

6.6

251

1812

D11AH01

ATC

tacrolimus; topical

4.2

6.6

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

8.7

6.6

KH1EE

NOMESCO Finland

Urologic ultrasound examination

8.7

6.6

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.6

6.5

141

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

6.5

264

1930

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

3.5

6.4

C09XA02

ATC

aliskiren; oral

70.1

6.4

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

70.1

6.4

KAB00

NOMESCO Finland

Biopsy of kidney or pelvis of kidney

70.1

6.4

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

3.3

6.4

D09AB01

ATC

zinc bandage without supplements; topical

2.9

6.4

102

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

6.4

249

1805

OAB72

NOMESCO Finland

Weight control and weight loss guidance

3.8

6.4

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

6.3

481

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

6.3

158

1042

J01EA01

ATC

trimethoprim; systemic

1.4

6.3

291

2174

WX872

NOMESCO Finland

Intensive care

1.9

6.3

402

RJ126, ,

NOMESCO Finland

11.1

6.3

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

9.3

6.3

H36.01

ICD-10 Finland

Diabetic maculopathy

3.4

6.3

RJ513, ,

NOMESCO Finland

18.1

6.3

V06DD

ATC

Amino acids, incl. combinations with polypeptides

+∞

6.3

N00.1

ICD-10 Finland

Acute nephritic syndrome, Focal and segmental glomerular lesions

+∞

6.3

PBG99

NOMESCO Finland

Operation for aneurysm of other artery of upper extremity

+∞

6.3

N08.8

ICD-10 Finland

Glomerular disorders in other diseases classified elsewhere

+∞

6.3

N00.7

ICD-10 Finland

Acute nephritic syndrome, Diffuse crescentic glomerulonephritis

+∞

6.3

5838X

ICD-9 Finland

Nephritis and nephropathy, not specified as acute or chronic, With other specified pathological lesion in kidney[NEPHRITIS INTERSTITIALIS CHRONICA ALIA DEFINITA]

+∞

6.3

D59.3

ICD-10 Finland

Haemolytic-uraemic syndrome

+∞

6.3

RS421, ,

NOMESCO Finland

+∞

6.3

N06.5

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, diffuse mesangiocapillary glomerulonephritis

+∞

6.3

PH9AT

NOMESCO Finland

Expansion (PTA) of vein not elsewhere classified

+∞

6.3

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

6.2

337

2587

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

6.2

238

0539X

ICD-9 Finland

Herpes zoster without mention of complication

26.8

6.2

OAB70

NOMESCO Finland

Guidance related to hydration

26.8

6.2

RJ514, ,

NOMESCO Finland

26.8

6.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

6.2

105

628

SDA03

NOMESCO Finland

Periodontal treatment

1.3

6.2

535

4416

WX320

NOMESCO Finland

Spinalanesthesy

1.4

6.2

328

2512

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.4

6.2

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.6

6.2

127

WX199

NOMESCO Finland

Other local analgesia

2.2

6.1

233

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.6

6.1

139

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.9

6.1

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.8

6.1

539

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

6.1

108

654

ZPB40

NOMESCO Finland

Polytetrafluoroethylene

12.6

6.1

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

12.6

6.1

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

12.6

6.1

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.4

6.1

158

KAC00

NOMESCO Finland

Nephrectomy

8.6

6.1

H04AA01

ATC

glucagon; nasal, parenteral

2.7

6.0

111

SCB02

NOMESCO Finland

Instructions for self-performed oral hygiene

10.1

6.0

N18.1

ICD-10 Finland

Chronic kidney disease, stage 1

10.1

6.0

NGQ20

NOMESCO Finland

Amputation of lower leg

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020779) Urea [Moles/volume] in Serum or Plasma

918

1213

17.42

307.65

24.1

6.5

12.98

9.41

mmol/l

29.85

904

1170

(3010375) cycloSPORINE [Mass/volume] in Blood

259

64.75

307.65

26.6

30.9

86.97

140.24

ug/l

4.67

224

(40768446) Kidney Pathology biopsy report

276

197.87

307.65

1.9

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

514

399

18.89

307.65

7.8

3.0

2.00

1.48

mg/l

15.62

500

359

(3003458) Phosphate [Moles/volume] in Serum or Plasma

975

1787

13.28

307.65

26.1

4.9

1.14

1.02

mmol/l

23.71

965

1662

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

331

296

13.99

307.65

9.9

5.5

534.66

356.72

iu/ml

0.36

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

732

926

14.24

307.65

12.5

3.2

170.98

81.56

ng/l

25.18

679

817

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

302

224

16.55

307.65

4.4

2.8

26112.38

2113.05

u/ml

—

(3020876) Protein [Mass/time] in 24 hour Urine

325

127

32.22

307.65

3.7

2.5

1.52

0.69

g/24h

6.42

262

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

272

232

14.04

275.37

11.3

2.7

15.74

8.29

pmol/l

11.00

272

232

(3000850) Epithelial cells [#/volume] in Urine

897

3022

5.76

256.69

9.3

2.6

3.01

5.12

e6/l

6.76

867

2765

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

699

1949

5.76

248.38

10.0

2.4

24.56

23.16

2.30

688

1820

(3004789) Transferrin [Mass/volume] in Serum or Plasma

713

2115

5.44

233.22

9.9

2.4

2.02

2.31

g/l

46.18

701

1962

(3042733) HLA Ab [Presence] in Serum

144

38.67

232.07

7.6

3.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

252

254

11.68

227.69

2.9

1.3

159.65

152.71

au/ml

0.30

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

257

275

11.03

222.54

2.9

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

257

279

10.87

220.18

2.8

1.3

18.62

16.30

u/ml

—

(3022948) Iron [Moles/volume] in Serum or Plasma

723

2261

5.17

219.52

9.8

2.4

12.26

13.30

umol/l

4.81

713

2109

(3020682) Albumin/Creatinine [Ratio] in Urine

1046

4535

5.13

205.56

14.6

4.0

46.43

6.20

mg/mmol

38.95

956

2887

(3012516) Albumin [Mass/volume] in Urine

1022

4445

4.91

197.40

11.9

3.3

243.56

38.12

mg/l

46.09

936

2934

(3002582) Erythrocytes [#/volume] in Urine

1014

4390

4.88

196.89

12.0

3.3

39.73

77.70

e6/l

1.60

926

3366

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

450

1031

5.77

194.43

5.3

2.8

42.09

68.26

ml/min/173m2

29.58

275

430

(3012544) pH of Venous blood

534

1430

5.20

192.39

13.8

3.4

7.36

7.38

13.66

388

820

(3009508) Creatinine [Moles/volume] in Urine

1045

4722

4.83

189.15

12.1

3.3

6.37

8.02

mmol/l

40.43

1003

4002

(3002032) Base excess in Venous blood by calculation

518

1371

5.20

188.89

14.2

3.3

0.32

1.91

mmol/l

17.15

467

1175

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

174

133

14.63

186.35

1.1

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

525

1421

5.10

186.02

14.0

3.3

5.79

5.82

kpa

0.20

518

1385

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

231

278

9.61

182.22

1.9

1.2

258.39

267.22

u/ml

0.13

173

164

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

174

140

13.90

180.72

2.2

2.5

23.61

54.45

iu/ml

0.95

(3026782) Osmolality of Urine

725

2584

4.43

178.97

10.1

2.8

478.10

545.09

mosm/kgh2o

20.05

696

2273

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

264

385

8.08

177.65

3.5

1.4

1.12

1.22

g/l

4.12

256

367

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

329

614

6.55

175.52

2.7

1.9

1.57

1.52

g/l

0.36

301

539

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

258

372

8.14

175.26

3.6

1.4

0.24

g/l

0.11

249

356

(3030467) Casts [#/volume] in Urine by Automated count

897

3776

4.32

174.73

11.3

3.2

0.14

0.45

e6/l

11.52

791

2780

(3026493) Urate [Moles/volume] in Serum or Plasma

869

3579

4.31

174.51

7.0

2.8

403.31

349.81

umol/l

40.21

828

3159

(3000991) Gas panel - Venous blood

473

1257

5.00

169.75

18.5

9.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1153

5893

4.88

169.67

19.2

5.1

34.38

35.60

g/l

12.53

1131

5561

(3018095) Leukocytes [#/volume] in Urine

1043

4973

4.45

168.49

14.3

3.8

33.87

105.38

e6/l

3.16

938

3536

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

114

27.91

166.52

1.1

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

102

37.61

163.79

1.1

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

272

448

7.17

163.39

2.8

4.0

57.96

49.02

mg/l

0.41

197

388

(3034860) Kappa light chains.free [Mass/volume] in Serum

272

448

7.17

163.39

2.8

4.0

86.69

57.62

mg/l

0.71

198

385

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

144

15.95

163.25

1.5

1.2

83.20

88.20

—

(3018418) pH of Serum or Plasma

901

3941

4.13

162.96

23.1

3.9

7.38

7.40

22.04

805

2817

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

256

400

7.49

161.42

2.8

3.8

3.92

3.63

ratio

0.04

122

229

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

258

432

6.98

152.15

4.0

2.8

0.29

0.36

iu/ml

1.51

120

230

(3009445) Proteinase 3 Ab [Units/volume] in Serum

297

575

6.17

151.47

2.0

1.4

18.24

18.81

iu/ml

0.01

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

42.89

148.01

4.1

2.7

35.14

20.48

mg/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

251

421

6.94

147.62

1.8

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

145

122

13.02

146.05

2.0

2.6

—

(3012565) Volume of 24 hour Urine

108

21.85

143.60

2.9

2.8

1824.42

2022.69

0.60

101

(3017143) Hepatitis C virus Ab [Presence] in Serum

485

1477

4.34

143.58

3.9

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

144

264.65

142.78

4.6

6.7

658.20

—

iu/ml

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

68.44

142.54

13.6

10.9

5.14

5.38

mmol/l

0.29

(3024354) Oxygen [Partial pressure] in Venous blood

429

1197

4.59

142.43

9.4

2.9

5.93

4.48

kpa

14.81

423

1168

(3020630) Protein [Mass/volume] in Serum or Plasma

406

1130

4.53

134.55

3.4

2.9

63.99

66.55

g/l

7.44

393

1047

(1616796) Gas panel - Central venous blood

206

309

7.55

134.01

9.0

3.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

611

2319

3.72

130.07

5.5

3.6

0.80

0.82

mmol/l

3.70

601

2199

(3004588) Protein electrophoresis panel - Serum or Plasma

353

915

4.72

127.60

2.6

2.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

576

2154

3.68

124.55

3.5

2.1

29.55

29.78

0.38

569

2090

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

524

1847

3.79

123.80

3.9

1.6

—

(3024471) HLA-A [Type]

24.17

123.68

1.0

—

(3024932) HLA-DR beta [Type]

23.88

121.73

1.0

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1055

5807

3.63

121.39

4.9

2.4

74.51

76.72

nmol/l

2.15

1027

5252

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

325

819

4.77

121.28

7.7

3.3

0.58

1.87

mmol/l

6.88

208

609

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1145

6671

3.85

119.66

36.9

7.0

1.21

mmol/l

1.80

1055

5759

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1070

5979

3.63

119.33

30.6

6.6

1.22

1.21

mmol/l

11.19

1058

5542

(3016750) Collection duration of Urine

109

14.06

116.21

3.9

2.2

496.73

498.07

min

0.04

101

(3009343) pH of Capillary blood

342

932

4.44

115.10

8.5

3.5

7.40

7.42

7.83

316

790

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

345

954

4.38

113.81

8.6

3.5

4.88

5.17

kpa

10.64

336

921

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

586

2351

3.42

111.39

7.0

2.9

0.55

0.98

e6/l

5.13

385

1249

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

467

1623

3.70

111.19

4.1

4.4

241.33

248.38

u/l

0.45

457

1546

(3030981) Hyaline casts [#/volume] in Urine by Automated count

371

1122

4.04

107.89

7.6

2.3

0.19

0.42

e6/l

2.98

366

1071

(3004775) Volume in Urine collected for unspecified duration

113

105

11.54

106.33

3.7

2.3

745.92

618.61

2.01

104

(3023520) Reticulocytes [#/volume] in Blood

386

1218

3.90

105.46

4.9

2.8

67.84

70.10

e9/l

0.59

262

910

(3024928) Oxygen saturation in Venous blood

198

366

6.07

104.50

7.8

3.2

73.11

59.47

12.56

193

360

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

20.77

103.30

3.1

2.4

0.59

0.62

mmol/l

0.85

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

230

496

5.28

102.54

1.6

1.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

446

1588

3.55

101.21

5.2

2.7

1.90

1.80

1.34

437

1427

(3014148) Varicella zoster virus Ab [Titer] in Serum

129

154

9.06

101.17

1.1

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

549

2229

3.28

100.65

3.9

1.8

—

(3037121) Protein [Mass/volume] in Urine

220

474

5.25

98.03

8.6

3.3

972.13

277.87

mg/l

4.61

179

203

(42870588) Differential panel, method unspecified - Blood

860

4582

3.00

96.36

11.0

6.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

533

2187

3.21

95.15

7.8

3.0

1.53

1.72

e6/l

0.23

333

1080

(3011648) Oxygen content in Venous blood

121

146

8.91

94.01

5.6

2.7

10.80

10.73

0.06

121

146

(3015736) pH of Urine

963

5525

3.00

92.95

8.5

3.3

6.21

6.19

0.17

569

3149

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

126

169

8.03

89.69

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

387

1389

3.39

85.16

5.4

3.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

1088

6872

3.02

84.31

11.1

3.6

0.00

estimate

0.33

354

1455

(3009261) Glucose [Presence] in Urine by Test strip

1098

6987

3.02

83.57

11.1

3.7

0.00

0.23

estimate

0.54

337

1370

(3035350) Ketones [Presence] in Urine by Test strip

1094

6960

3.01

83.06

11.1

3.7

14.34

5.78

estimate

0.58

361

1484

(3042936) Bacteria identified in Isolate by Culture

477

1994

3.02

80.44

3.1

2.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

173

360

5.29

79.71

3.2

1.2

11.87

5.38

iu/ml

—

(3023368) Bacteria identified in Blood by Culture

730

3873

2.69

77.39

9.5

4.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

139

244

6.17

76.83

3.1

1.3

17.79

10.60

u/ml

—

(3012501) Base excess in Blood by calculation

144

270

5.78

74.28

9.3

3.9

2.14

2.47

mmol/l

0.70

184

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

297

987

3.49

72.95

2.2

1.7

—

(3019069) Monocytes/Leukocytes in Blood

1003

6358

2.68

71.84

13.1

6.7

9.06

8.99

0.39

978

5969

(3006504) Eosinophils/Leukocytes in Blood

1001

6351

2.67

71.36

13.1

6.6

2.86

2.85

0.03

978

5959

(3001604) Monocytes [#/volume] in Blood

1055

6873

2.72

71.16

12.5

6.3

0.64

0.59

e9/l

6.31

951

5891

(3006315) Basophils [#/volume] in Blood

1055

6886

2.71

70.65

12.5

6.3

0.04

e9/l

0.53

951

5901

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

152

316

5.23

69.90

4.9

2.4

367.22

81.88

ug/min

3.55

128

191

(3022096) Basophils/Leukocytes in Blood

997

6352

2.64

69.80

13.2

6.6

0.61

0.68

3.84

972

5956

(3023420) DNA double strand Ab [Units/volume] in Serum

200

523

4.25

69.30

4.3

1.6

10.92

7.82

iu/ml

0.52

120

(3019198) Lymphocytes [#/volume] in Blood

1060

7006

2.67

67.92

12.7

6.4

1.86

1.92

e9/l

0.24

971

6176

(3002030) Lymphocytes/Leukocytes in Blood

1006

6497

2.60

67.43

13.2

6.6

25.06

27.36

9.78

989

6167

(3037756) Immunofixation for Serum or Plasma

142

288

5.33

67.10

1.6

1.7

—

(3013115) Eosinophils [#/volume] in Blood

1067

7098

2.66

67.04

13.0

6.6

0.20

0.19

e9/l

0.83

971

6209

(3018010) Neutrophils/Leukocytes in Blood

992

6380

2.58

66.82

12.6

6.5

60.00

57.49

9.62

975

6097

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

546

4.09

66.05

2.6

7.54

7.24

g/l

1.53

193

507

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

546

4.06

65.24

2.6

4.00

4.17

g/l

1.82

192

507

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

546

4.06

65.24

2.6

3.93

3.72

g/l

0.99

193

507

(3021589) Normoblasts [#/volume] in Blood

941

5946

2.51

65.17

29.0

11.5

0.00

e9/l

0.95

779

4875

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

473

4.23

63.41

2.8

2.7

9.39

10.47

g/l

2.28

173

431

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

290

1033

3.23

63.05

19.1

3.5

1.22

mmol/l

0.51

285

893

(3014111) Lactate [Moles/volume] in Serum or Plasma

341

1336

3.00

62.86

14.7

8.5

1.17

1.34

mmol/l

3.38

341

1312

(3006184) Hemoglobin [Mass/volume] in Capillary blood

148

330

4.86

62.57

4.6

2.2

124.84

131.59

g/l

2.31

139

254

(3005719) IgG [Mass/volume] in Serum or Plasma

299

1090

3.17

62.48

4.1

2.8

9.38

10.81

g/l

5.58

283

1011

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

125

247

5.42

60.71

1.7

1.2

206.00

465.00

titre

0.62

(3001122) Ferritin [Mass/volume] in Serum or Plasma

941

6082

2.42

59.89

9.0

3.0

216.41

140.10

ug/l

15.33

916

5677

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

187

521

3.95

59.10

2.7

2.6

3.15

2.93

g/l

2.19

179

482

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

484

2354

2.54

57.93

2.8

1.9

—

(3035715) Granulocytes [#/volume] in Blood

120

239

5.36

57.73

4.2

3.4

4.57

4.20

e9/l

0.85

120

239

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

400

1778

2.69

57.57

2.4

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

155

386

4.36

56.96

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

165

432

4.16

56.74

2.5

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

384

1684

2.71

56.67

2.5

1.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

153

379

4.37

56.61

1.7

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

158

411

4.17

54.77

2.9

2.6

0.01

0.00

g/l

0.50

145

361

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

151

381

4.29

54.50

2.9

2.7

0.00

g/l

-0.00

145

360

(3021879) Hepatitis B virus core Ab [Presence] in Serum

270

999

3.07

54.50

2.3

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

103

188

5.80

54.43

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

160

422

4.12

54.42

2.9

2.6

0.19

0.02

g/l

0.49

150

383

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

172

482

3.89

53.77

2.8

2.6

0.32

1.23

g/l

3.11

157

425

(3037522) Nuclear Ab [Titer] in Serum

399

1836

2.59

53.00

1.6

1.3

381.15

494.12

titre

1.14

391

(3031040) Bacteria [#/volume] in Urine by Automated count

1153

8396

2.51

52.73

9.0

4.5

106.29

1068.22

e6/l

1.88

127

(3033658) Prothrombin time (PT) actual/Normal

615

3449

2.31

52.47

7.8

4.3

96.09

88.29

9.76

600

3379

(3035933) Granulocytes/Leukocytes in Blood

130

306

4.55

51.24

4.5

3.2

60.59

57.73

1.66

130

306

(3026008) Bacteria identified in Urine by Culture

641

3690

2.27

51.03

4.3

3.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

739

4516

2.23

50.72

7.9

3.4

2.33

2.35

mmol/l

2.99

714

4114

(3002179) Metamyelocytes/Leukocytes in Blood

294

1184

2.84

50.63

7.1

4.5

0.55

0.68

0.71

130

375

(3013650) Neutrophils [#/volume] in Blood by Automated count

1073

7647

2.35

50.22

15.6

9.9

4.46

4.16

e9/l

3.80

981

6648

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

152

411

4.00

49.87

1.6

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

635

3671

2.25

49.71

6.8

2.8

0.50

0.03

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

118

264

4.76

49.49

1.7

—

(3017181) Myelocytes/Leukocytes in Blood

302

1250

2.76

49.26

7.4

4.6

0.92

0.94

0.06

136

397

(3025159) Blasts/Leukocytes in Blood

292

1204

2.76

47.88

7.7

4.9

0.02

0.16

2.66

120

316

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

127

311

4.36

47.54

1.9

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

646

3813

2.20

47.49

12.0

3.8

0.02

0.00

estimate

0.82

277

1348

(3021440) Promyelocytes/Leukocytes in Blood

289

1194

2.75

47.15

7.7

4.7

0.06

0.12

0.80

124

344

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

128

319

4.29

46.82

1.6

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

117

274

4.54

46.35

1.6

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

345

1573

2.54

46.01

2.8

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

141

385

3.93

45.55

2.9

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

193

5.07

42.57

1.8

1.6

—

(3047189) Immunofixation for 24 hour Urine

8.94

41.55

2.0

1.9

—

(3022313) Gas panel - Capillary blood

187

656

3.11

40.83

9.9

3.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

122

329

3.94

40.02

1.6

—

(3032080) INR in Blood by Coagulation assay

900

6296

2.04

39.61

26.6

15.2

1.25

1.26

inr

0.21

794

5248

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

142

428

3.55

39.60

3.5

2.6

3.99

3.65

g/l

1.29

137

409

(3028271) Lactate [Moles/volume] in Capillary blood

206

4.74

39.39

2.8

1.8

1.36

1.69

mmol/l

3.20

197

(40761536) Microorganisms panel - Urine sediment

251

1055

2.65

39.09

16.0

3.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

582

3506

2.07

38.61

3.2

2.3

2.96

2.86

mg/l

0.48

535

3010

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

778

5229

1.99

37.64

11.1

3.6

0.00

0.03

estimate

2.42

324

1210

(3022493) Free Hemoglobin [Mass/volume] in Plasma

8.40

37.34

1.7

5.0

54.52

65.56

mg/l

0.54

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

173

611

3.06

37.23

2.4

1.8

4.75

2.04

ug/l

0.69

162

553

(3028026) IgM [Mass/volume] in Serum or Plasma

214

860

2.73

36.29

2.5

1.9

1.28

1.39

g/l

0.25

201

803

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

116

5.90

36.18

1.8

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1256

10118

2.35

36.17

19.8

8.4

80.30

79.84

u/l

0.15

1235

9643

(3036525) Urea [Moles/time] in 24 hour Urine

70.05

36.12

2.8

4.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

124

5.69

35.87

1.3

1.2

85.82

51.19

u/l

1.62

112

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

105

275

4.03

35.82

1.8

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

235

1001

2.59

35.42

2.8

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

601

3768

1.98

34.77

10.0

3.2

0.09

0.03

estimate

0.33

284

1139

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

138

449

3.28

34.02

1.9

1.5

2.01

0.08

iu/ml

0.69

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

226

4.22

33.33

1.7

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

185

724

2.77

32.89

1.9

1.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

651

4256

1.92

32.76

4.3

2.6

67.82

79.79

u/l

0.28

628

3969

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

7.26

32.33

1.2

1.0

1697.65

1610.76

miu/ml

0.18

(3013826) Glucose [Moles/volume] in Serum or Plasma

1037

7954

1.94

31.30

14.0

5.4

6.87

6.72

mmol/l

1.31

1019

7590

(3021960) Folate [Moles/volume] in Serum or Plasma

599

3855

1.91

31.24

2.2

1.7

19.57

19.92

nmol/l

0.21

554

3280

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

946

7075

1.88

30.45

8.0

6.9

9.69

11.94

umol/l

13.12

915

6779

(3036481) Cortisol [Moles/volume] in Serum or Plasma

265

1274

2.31

30.33

2.3

2.2

323.98

377.91

nmol/l

4.90

255

1188

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

6.80

29.86

4.6

1.7

139.96

103.73

ng/l

1.12

(3045414) Leukocytes [Presence] in Urine

257

1234

2.30

29.45

4.4

2.0

0.00

0.02

estimate

0.78

267

(4035726) Immunohistochemistry procedure

243

1141

2.34

29.32

1.7

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

143

523

2.91

28.74

10.4

3.7

23.61

24.97

mmol/l

7.32

134

493

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

523

3293

1.89

28.61

4.0

2.5

—

(3044640) Blood type and Crossmatch panel - Blood

643

4327

1.84

28.43

4.3

2.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

381

2186

1.99

27.29

2.2

1.7

1341.75

1148.81

nmol/l

2.56

318

1678

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

198

4.04

26.90

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

485

3041

1.87

26.48

10.3

4.8

—

(3016502) Oxygen saturation in Arterial blood

287

1508

2.11

26.05

13.0

9.1

93.76

95.51

2.76

281

1464

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

127

4.79

25.84

1.7

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

7.66

25.53

1.9

2.8

481.00

563.14

u/ml

—

(40758558) Short blood count panel - Blood

595

4030

1.78

24.85

9.4

6.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

612

4183

1.77

24.75

2.8

2.2

194.90

231.77

u/l

0.46

590

3982

(3052851) Hemolysis interference index of Serum or Plasma

103

341

3.17

24.59

4.2

3.6

2.35

1.95

index

0.36

188

(3045424) Erythrocytes [Presence] in Urine

157

653

2.56

24.52

4.7

2.1

0.16

1.22

estimate

0.41

209

(3019977) pH of Arterial blood

304

1674

2.02

24.14

12.8

8.9

7.40

7.41

0.92

158

916

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

5.24

23.44

1.7

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

146

604

2.57

23.02

1.6

2.0

40.39

39.17

u/l

0.24

133

534

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

302

1688

1.98

22.88

12.9

8.8

5.04

5.12

kpa

0.76

296

1629

(3027801) Oxygen [Partial pressure] in Arterial blood

302

1689

1.98

22.84

12.9

8.8

11.16

12.17

kpa

2.56

295

1633

(3049717) Cytology report of Urine Cyto stain

138

571

2.56

21.73

2.5

2.7

—

(3000012) Reticulocyte production index

198

3.66

21.38

2.2

2.4

0.89

0.91

0.12

141

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

5.18

21.26

1.8

1.5

—

(3003396) Base excess in Arterial blood by calculation

294

1668

1.94

21.18

13.0

8.8

-0.25

0.95

mmol/l

4.85

246

1371

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

310

3.06

20.69

1.7

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

242

1294

2.03

20.61

3.6

2.6

94.65

42.51

u/l

0.46

209

1099

(3036489) Thrombin time

129

533

2.55

20.36

2.7

2.2

22.87

21.07

1.35

119

486

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

5.17

20.31

1.8

1.5

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

15.79

19.30

2.3

1.1

103.68

97.10

0.53

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

5.39

19.25

1.4

1.2

16.39

20.52

u/l

0.50

(44790049) Parainfluenza type 3 nucleic acid detection

188

3.51

18.50

1.4

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

188

3.51

18.50

1.4

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

188

3.51

18.50

1.4

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

188

3.51

18.50

1.4

1.6

—

(3025941) Bacteria identified in Stool by Culture

146

670

2.30

18.27

1.4

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

5.10

18.14

1.4

1.2

67.27

88.91

u/l

1.16

(3007164) IgA [Mass/volume] in Serum or Plasma

398

2637

1.69

16.65

2.0

1.5

2.83

2.51

g/l

2.20

299

1649

(3024139) IgG subclass 3 [Mass/volume] in Serum

134

3.82

16.54

2.0

1.3

0.49

0.39

g/l

1.03

(3028192) IgG subclass 2 [Mass/volume] in Serum

134

3.82

16.54

2.0

1.3

2.74

2.92

g/l

0.23

(3027135) IgG subclass 1 [Mass/volume] in Serum

134

3.82

16.54

2.0

1.3

7.39

6.81

g/l

0.22

(3002079) Sodium [Moles/time] in 24 hour Urine

5.75

16.36

1.2

1.4

118.53

182.43

mmol/24h

3.41

(4062490) Immunoglobulin typing, IgG

132

3.80

16.09

1.9

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

786

6174

1.56

16.05

4.6

2.9

—

estimate

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

170

880

2.05

15.65

2.2

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

195

3.22

15.46

1.8

1.4

24.46

32.56

g/l

3.54

177

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

312

2.72

15.26

2.1

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

4.81

15.22

1.6

8.58

6.24

u/l

0.35

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

373

2.56

15.09

1.5

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

11.93

15.08

1.4

1.2

14.13

9.95

pmol/l

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

386

2.53

15.02

1.8

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

11.43

14.79

1.6

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

217

3.03

14.70

1.1

1.2

5.11

3.63

u/ml

0.18

(3017704) Immunofixation for Urine

4.51

14.52

1.4

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.73

14.50

2.2

2.4

—

(4268621) Lupus anticoagulant assay

149

3.44

14.18

2.4

2.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

370

2.49

13.87

1.6

2.2

16.45

11.33

mg/l

3.62

339

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

182

3.16

13.83

2.3

2.5

33.00

32.62

0.30

182

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

214

2.98

13.82

1.3

1.2

3.53

5.55

u/ml

0.60

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

230

1370

1.80

13.81

2.0

2.3

0.22

0.21

g/l

1.41

217

1285

(3024980) IgG subclass 4 [Mass/volume] in Serum

237

2.87

13.71

2.0

1.6

0.57

0.77

g/l

0.96

189

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

111

514

2.25

13.57

3.1

2.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

169

3.21

13.51

1.6

1.4

1799.62

1706.71

e6/l

0.04

115

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

551

4118

1.53

13.36

3.8

3.2

7112.00

1258.82

ng/l

13.03

507

3536

(3051651) Icteric interference index of Serum or Plasma

4.52

13.34

5.7

4.2

0.75

0.92

index

0.60

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

744

5924

1.50

13.29

2.5

2.1

102.21

95.05

pmol/l

3.63

430

3271

(3000093) Morphology [Interpretation] in Blood Narrative

133

3.46

12.94

1.5

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

127

3.45

12.39

1.2

1.1

350.00

200.00

titre

—

(3044927) Protein electrophoresis panel - Urine

147

3.27

12.38

1.3

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

378

2.38

12.33

1.7

1.2

20.07

36.68

u/ml

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

658

5164

1.48

12.31

5.8

3.8

73.80

82.33

ng/l

0.12

543

3695

(3000494) Fungus identified in Specimen by Culture

265

1697

1.68

12.21

1.7

1.5

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1111

9693

1.53

12.15

8.0

4.3

22.20

11.72

mm/h

45.22

1078

9058

(40768443) Skin Pathology biopsy report

116

572

2.11

12.13

1.2

—

(3012441) Differential panel - Pleural fluid

149

3.22

12.12

1.9

1.4

—

(21494814) CD8 cells/Lymphocytes in Specimen

5.28

12.03

2.0

1.8

32.54

29.80

0.31

(3042631) Mycobacterium sp identified in Specimen

195

2.89

11.72

3.0

2.8

—

(40768806) Pleura Pathology biopsy report

149

3.15

11.46

1.9

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

359

2.36

11.44

1.8

1.2

12.65

2.47

u/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

360

2.35

11.37

1.8

1.2

5.61

11.51

u/ml

0.58

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

15.16

11.31

3.0

5.9

—

(3025549) Creatine [Moles/time] in 24 hour Urine

20.19

11.13

1.1

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

4.20

11.09

1.6

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

4.20

11.09

1.6

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

244

1573

1.66

10.88

3.5

2.9

6.86

8.02

umol/l

0.58

214

1397

(3036782) Glucose [Moles/volume] in Pleural fluid

153

3.00

10.36

1.7

1.3

6.98

6.37

mmol/l

0.49

145

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

122

3.25

10.31

5.2

2.6

—

(21494815) CD4 cells/Lymphocytes in Specimen

107

3.42

10.31

2.2

2.1

40.79

38.85

0.28

107

(3051611) Lipemic interference index of Serum or Plasma

113

3.33

10.16

5.4

3.9

15.88

12.37

index

0.75

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

166

2.89

10.12

3.0

1.9

—

1885.71

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

11.37

10.06

3.1

5.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

266

2.47

10.03

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

266

2.47

10.03

1.5

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

14.68

10.00

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

146

3.00

9.93

1.7

1.4

215035.41

73866.72

e6/l

0.29

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

377

2.21

9.82

1.2

1.3

155.64

212.74

miu/ml

0.50

165

(3045788) Cell count panel - Pleural fluid

142

3.01

9.77

1.6

1.4

—

(3003181) Sodium [Moles/volume] in Urine

242

2.50

9.52

1.7

1.3

51.13

61.36

mmol/l

1.56

197

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

375

2744

1.49

9.46

2.0

1.7

460.90

25812465.77

pmol/l

2.12

348

2309

(3017569) Oxygen content in Arterial blood

3.58

9.25

2.1

2.9

15.78

16.74

0.53

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1183

10665

1.48

9.22

56.8

20.0

14.11

13.63

26.70

1178

10533

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

579

4615

1.41

9.17

4.0

3.3

32.83

37.49

u/l

0.62

560

4367

(3000034) Microalbumin [Mass/volume] in Urine

121

3.11

9.12

7.3

3.3

420.01

31.09

mg/l

2.20

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

151

2.83

8.79

1.5

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.89

8.70

3.4

4.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

142

2.87

8.57

1.5

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

126

2.98

8.54

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

126

2.98

8.54

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

126

2.98

8.54

1.5

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

395

2971

1.44

8.53

2.3

1.8

1.91

1.23

mg/l

3.65

342

2313

(3000570) Elastase.pancreatic [Mass/mass] in Stool

416

2.05

8.36

1.6

1.5

234.96

278.56

ug/g

1.23

253

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

139

2.85

8.31

1.1

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

228

2.42

8.23

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

151

2.76

8.23

1.1

—

(3004451) EKG impression Narrative

100

3.14

7.85

1.5

1.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

175

2.56

7.62

1.2

1.1

—

27.40

—

(3018333) Ribosomal P Ab [Presence] in Serum

3.16

7.43

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

6.00

7.38

13.2

7.6

9.13

4.98

kpa

4.41

(3011985) Renin [Units/volume] in Plasma

172

2.54

7.37

1.2

1.3

73.75

53.75

mu/l

0.33

156

(3017732) Neutrophils [#/volume] in Blood

242

1700

1.50

7.30

3.3

3.4

4.89

4.88

e9/l

0.01

229

1483

(3048689) Calprotectin [Mass/mass] in Stool

233

1629

1.51

7.19

2.7

2.6

161.32

130.35

ug/g

0.81

203

1317

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1302

12128

1.49

7.13

11.1

6.4

39.84

39.37

mmol/mol

1.05

1272

11391

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

3.06

7.06

1.2

1.1

—

(3034426) Prothrombin time (PT)

4.22

7.02

1.2

1.3

27.06

28.53

0.71

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

3.03

6.94

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

125

2.76

6.89

1.9

1.4

25.27

30.76

0.39

(3000475) Leukocytes [#/volume] in Synovial fluid

370

1.99

6.82

2.0

1.6

20385.37

15152.37

e6/l

0.22

256

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

351

2678

1.40

6.80

5.4

3.9

364.65

453.77

ng/l

0.24

305

2108

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

176

1178

1.56

6.62

2.7

2.4

5.03

7.86

ug/l

1.89

159

1062

(3035880) pH of Pleural fluid

3.28

6.57

1.5

1.3

7.44

7.40

0.41

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

101

2.91

6.49

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

101

2.91

6.49

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

101

2.91

6.49

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

464

3738

1.35

6.35

1.7

1.4

—

(3000330) Specific gravity of Urine by Test strip

105

624

1.73

6.32

9.7

3.5

1.02

ratio

2.65

100

588

(3024891) Influenza virus A+B Ag [Presence] in Specimen

354

1.96

6.23

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

448

1.85

6.20

1.9

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.14

6.09

1.2

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

158

2.44

6.06

2.1

1.5

65.93

57.66

0.62

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1348

12728

1.50

6.06

51.4

16.3

20.68

25.32

mg/l

8.96

1240

10533

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

343

2653

1.38

6.05

3.5

3.0

2.47

2.45

mmol/l

2.00

307

2398

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

5.20

6.01

1.1

1.0

—

(3022689) Creatine [Moles/volume] in Urine

3.90

5.99

2.3

1.3

7.38

8.31

mmol/l

0.33

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

4.03

5.90

1.6

1.3

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

107

2.74

5.87

1.2

1.1

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

6.41

5.86

1.6

1.7

6.13

8.64

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.97

5.85

2.1

2.6

7.44

8.18

mmol/l

0.58

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1290

12104

1.42

5.76

7.2

4.3

1.56

1.31

mmol/l

9.98

1254

11175

(3005532) Lymphocytes/Leukocytes in Pleural fluid

3.49

5.74

1.9

1.4

61.43

60.67

0.03

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

120

2.62

5.73

1.5

1.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1313

12364

1.44

5.69

47.2

15.7

56.61

81.69

ml/min/173m2

143.01

1276

11459

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.06

5.66

1.0

1.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

3.42

5.59

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.42

5.59

1.2

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.42

5.59

1.2

1.9

—

(3022145) Colonoscopy Study observation

212

1528

1.45

5.58

1.4

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

3.57

5.33

2.0

1.4

4.27

0.99

0.51

(3019150) Specific gravity of Urine by Refractometry

382

3058

1.33

5.32

10.8

3.8

1.02

1.51

kg/l

0.50

299

2056

(40768804) Tissue Pathology biopsy report

603

5138

1.29

5.29

2.7

2.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

5.04

5.25

1.1

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

102

2.68

5.25

2.0

0.68

1.52

u/field

0.98

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

120

2.53

5.22

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

+∞

5.21

1.6

0.0

1.20

—

(3008037) Lactate [Moles/volume] in Venous blood

342

1.88

5.15

6.3

2.9

1.29

1.56

mmol/l

2.47

332

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.87

5.09

2.1

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

13.39

5.08

1.1

1.0

—

(3023419) Bacteria identified in Sputum by Culture

205

2.13

5.05

2.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.19

5.05

2.4

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.19

5.05

2.4

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.98

4.99

1.3

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.98

4.99

1.3

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.98

4.99

1.3

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.98

4.99

1.3

1.8

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

6.92

4.95

3.8

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.18

4.77

1.2

1.9

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

151

2.28

4.75

1.1

1.3

—

nmol/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1441

0.62

4.73

2.0

2.1

3.89

3.59

ratio

0.73

1146

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

145

2.30

4.72

1.1

1.3

0.22

0.18

nmol/l

0.77

118

(3019550) Sodium [Moles/volume] in Serum or Plasma

1369

13074

1.45

4.70

60.2

19.1

139.30

139.70

mmol/l

7.37

1358

12827

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

112

734

1.57

4.66

2.5

3.7

4.15

4.57

pmol/l

3.22

103

655

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

878

7906

1.26

4.65

3.5

2.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

362

2926

1.31

4.64

1.4

1.3

1.07

1.69

u/ml

1.33

113

809

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

14.05

4.58

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.74

4.52

2.2

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

4.20

4.52

1.0

1.8

104.33

95.62

—

(3002256) Pathology report gross observation

233

1772

1.37

4.49

1.5

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

264

1.92

4.48

3.9

3.3

0.85

0.83

nmol/l

0.09

212

(3016650) Hepatitis A virus Ab [Presence] in Serum

243

1.96

4.48

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.25

4.46

1.8

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1369

13101

1.43

4.38

63.5

19.2

4.16

3.98

mmol/l

68.32

1357

12837

(3004616) Nuclear Ab [Presence] in Serum

157

2.19

4.36

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

356

1.77

4.29

1.3

1.1

—

(3019225) pH of Specimen

168

1218

1.43

4.29

20.8

4.0

7.36

7.35

0.46

157

893

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

358

1.76

4.21

1.3

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

127

876

1.49

4.20

1.4

1.3

247.93

251.67

u/ml

0.02

115

819

(42529406) Shigella sp [Presence] in Stool by Culture

360

1.75

4.14

1.3

1.1

—

(3045142) Bone marrow Pathology biopsy report

154

2.17

4.13

1.5

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

280

2218

1.32

4.11

1.3

16.32

12.10

u/ml

0.31

109

872

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

4.03

4.10

1.0

1.2

95.20

90.05

—

(40768797) Stomach Pathology biopsy report

242

1878

1.34

4.09

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

415

1.69

4.07

1.3

1.2

66.36

97.61

titre

1.14

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

104

2.43

4.07

1.2

1.1

76.20

106.83

pmol/l

2.14

104

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.04

3.97

1.0

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1053

9773

1.25

3.88

4.6

4.2

14.83

14.78

pmol/l

0.22

999

8969

(21494755) Public health laboratory ask at order entry panel

1198

0.63

3.84

1.3

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.62

3.81

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.55

3.80

2.2

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.55

3.80

1.4

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

8.78

3.77

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

8.78

3.77

26.6

4.4

115.29

99.38

g/l

—

(37208534) Antinuclear antibody arbitrary concentration in serum

3.13

3.65

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

2.49

3.64

2.5

2.9

38.90

39.53

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.02

3.59

1.1

1.3

—

(3044007) Cell count panel - Peritoneal fluid

3.74

3.59

2.6

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

4.57

3.43

1.3

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

2.36

3.41

1.2

1.1

—

100.44

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

295

2414

1.28

3.36

1.4

1.3

46.67

31.26

iu/ml

0.58

102

735

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.38

3.32

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.63

3.30

1.1

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

2.63

3.30

1.9

1.3

4.40

5.09

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1056

0.65

3.20

1.7

1.8

3.52

3.51

mmol/l

0.03

760

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.87

3.19

1.1

—

(3019174) dRVVT (LA screen)

6.39

3.18

1.6

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

4.02

3.08

2.6

1.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

139

2.03

3.06

1.5

1.3

228325.00

111611.71

e6/l

0.21

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.02

3.05

1.5

2.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

107

2.17

2.97

1.0

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

191

1.85

2.94

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.33

2.91

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

142

1.99

2.91

6.0

4.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

236

1.76

2.90

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

611

1.47

2.89

1.2

1.1

—

0.87

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1315

12649

1.28

2.88

8.3

5.0

1.36

1.42

mmol/l

7.44

1278

11773

(44806071) Cardiolipin IgM antibody measurement

4.46

2.79

1.0

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

285

1.67

2.78

7.7

3.0

6.69

7.46

mmol/l

2.12

276

(3008295) Osmolality of Serum or Plasma

152

1.93

2.76

1.1

1.4

271.43

280.37

mosm/kgh2o

1.35

117

(3028433) Virus identified in Specimen by Culture

3.25

2.72

1.0

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.72

2.5

2.2

293.25

915.00

e6/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.02

2.69

2.6

1.8

9466.40

40132.46

e6/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.23

2.68

1.1

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.35

2.60

1.0

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1318

12713

1.27

2.60

8.4

5.1

4.35

4.58

mmol/l

14.48

1286

11922

(3044009) aPTT.lupus sensitive (LA screen)

5.47

2.54

1.7

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.39

2.47

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.39

2.47

1.0

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

123

1.97

2.46

1.3

1.1

—

70.43

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

2.68

2.45

1.2

60.00

57.16

0.09

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.15

2.45

1.6

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

2.25

2.44

1.8

1.2

9.52

6.33

ug/l

0.92

(3002619) Bacteria identified in Specimen by Culture

3.14

2.43

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

103

2.05

2.42

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

299

1.59

2.35

5.0

1.5

1.27

0.84

nmol/l

2.32

256

(21494434) Karyotype in Bone marrow

128

1.89

2.22

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

323

0.49

2.20

1.6

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1329

12880

1.24

2.18

8.7

5.8

2.43

2.69

mmol/l

25.58

1295

12017

(3001019) Free T4 and TSH panel - Serum or Plasma

622

0.63

2.18

1.5

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

198

0.40

2.17

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

597

1.39

2.15

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

632

1.38

2.14

2.5

2.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

522

1.42

2.12

3.0

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

607

5543

1.16

2.08

2.7

1.9

1.62

1.38

mmol/l

3.67

540

4662

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.01

2.07

1.0

1.3

—

(3033099) Centromere Ab [Titer] in Serum

3.51

2.05

1.1

1.2

—

(4195642) Thrombophilia screening test

200

1.66

2.03

1.1

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.56

1.94

3.2

2.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.57

1.94

1.6

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

142

1.77

1.93

1.3

—

(3020650) Glucose [Presence] in Urine

2.45

1.93

1.3

1.2

0.00

0.07

estimate

0.49

(3016018) Differential panel - Cerebral spinal fluid

158

1.72

1.89

1.6

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.19

1.88

1.1

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

3.54

1.84

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

215

1.59

1.80

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

401

4458

0.86

1.76

3.8

4.5

27.60

21.42

9.17

218

2141

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.10

1.76

8.8

2.9

0.68

1.21

0.85

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.23

1.74

1.2

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

323

1.47

1.73

2.3

2508.06

3180.17

u/l

0.10

125

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

307

1.48

1.72

1.6

1.4

10.26

42.54

e6/l

0.83

226

(40761511) CBC panel - Blood by Automated count

1346

13124

1.21

1.69

43.1

14.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

643

1.32

1.66

1.7

0.27

0.33

mg/l

0.58

327

(3014891) Appearance of Pleural fluid

3.17

1.66

2.0

1.2

—

(40757373) Influenza virus identified in Isolate

2.81

1.65

1.1

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

479

1.37

1.65

2.8

1.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.58

1.61

2.4

2.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

421

1.39

1.61

1.5

1.6

355.25

276.09

mu/l

1.48

389

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

313

1.45

1.58

1.7

1.4

538.68

892.06

e6/l

0.22

239

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

553

1.34

1.57

2.8

3.6

1143.20

2622.79

u/ml

0.35

479

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

161

1.63

1.53

1.9

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.60

1.51

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.86

1.50

1.0

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

170

0.47

1.46

1.5

1.6

—

(40768795) Lymph node Pathology biopsy report

117

1.72

1.45

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

164

1.60

1.43

1.9

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1202

12362

0.87

1.42

7.7

5.1

6.04

5.97

mmol/l

0.88

1155

11379

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

157

1.60

1.41

1.9

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

157

1.60

1.41

1.9

1.5

—

(40768441) Liver Pathology biopsy report

111

1.72

1.39

1.4

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

211

0.52

1.38

1.4

1.6

66.25

57.70

ug/l

0.27

179

(1761482) Bacteria [#/volume] in Urine by Culture

297

1.43

1.38

7.7

4.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

936

8943

1.12

1.38

4.8

3.4

56.34

52.37

u/l

0.50

912

8461

(3005988) Vibrio sp identified in Specimen by Organism specific culture

158

1.59

1.38

1.9

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

452

1.34

1.37

1.4

1.6

8.55

11.27

u/ml

0.39

104

(3005033) Fetal Nuchal fold Thickness US

163

0.49

1.36

1.5

1.11

1.31

—

118

(3047352) Trisomy 18 risk [Likelihood] in Fetus

164

0.49

1.35

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

358

1.38

1.35

1.4

1.3

611.78

550.20

mg/l

0.20

334

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.14

1.33

1.1

—

(4146454) Self-monitoring of blood glucose

148

0.47

1.32

3.6

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.29

1.27

1.9

3.0

9.63

10.26

kpa

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.29

1.27

1.9

3.0

4.91

4.83

kpa

—

(3052592) Norovirus Ag [Presence] in Stool

2.64

1.21

1.6

1.3

—

(40768800) Prostate Pathology biopsy report

360

0.66

1.21

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

164

1.53

1.20

1.9

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

237

0.59

1.18

1.6

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

127

1071

1.20

1.18

3.5

3.0

510.56

198.50

ng/l

2.89

117

982

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.94

1.17

1.1

1.6

38.86

40.19

g/l

0.28

(4027681) Cerebrospinal fluid IgG ratio and IgG index

1.78

1.17

1.5

1.2

0.53

ratio

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

150

1.54

1.14

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

143

1.55

1.11

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

234

1.42

1.11

1.9

1.6

—

(37021550) Renin [Units/volume] in Plasma --upright

2.19

1.08

1.0

1.3

92.30

78.23

mu/l

—

(3047181) Lactate [Moles/volume] in Blood

400

1.31

1.07

7.1

7.0

1.39

1.33

mmol/l

0.12

353

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

163

1418

1.17

1.07

3.2

4.4

14.28

20.37

ug/l

0.29

132

1162

(3022621) pH of Urine by Test strip

120

1020

1.19

1.04

5.0

2.4

5.91

6.06

1.35

686

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

138

1.53

1.03

1.2

—

titre

—

(3044290) Cell count panel - Cerebral spinal fluid

291

1.35

1.00

1.6

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

131

1.53

1.00

1.1

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.81

0.98

1.0

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.95

0.97

2.3

1.7

18.00

14.81

pmol/l

—

(3032773) Endomysium IgG Ab [Titer] in Serum

124

1.54

0.97

1.1

—

titre

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

108

1.58

0.96

1.1

1.6

19.47

13.08

umol/l

1.49

101

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

157

1.47

0.96

4.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

865

0.81

0.95

1.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.77

0.94

1.2

1.3

3.84

5.12

umol/l

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.23

0.93

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1367

13460

1.15

0.91

27.2

12.2

23.72

27.44

u/l

21.11

1345

13112

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

107

914

1.18

0.91

2.2

2.5

16.53

18.02

au/ml

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.60

0.90

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

1.75

0.90

1.5

1.1

—

74.63

—

(3024263) Appearance of Synovial fluid

1.70

0.89

2.1

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.79

0.88

1.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

111

1.54

0.88

1.5

1.31

1.07

promille

0.23

(3023383) Lactate [Moles/volume] in Pleural fluid

1.86

0.87

1.1

1.4

3.60

3.09

mmol/l

—

(3048879) Bone marrow aspiration report

1.94

0.84

1.3

2.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

327

1.29

0.84

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

169

1512

1.13

0.79

1.6

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.8

—

0.62

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.82

0.79

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

131

1.46

0.78

1.3

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

217

1.34

0.77

1.0

1.1

252.00

91.07

iu/ml

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1379

13609

1.13

0.77

59.4

20.9

162.68

78.75

umol/l

82.88

1370

13456

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

142

1593

0.88

0.75

6.7

4.9

32.62

31.75

0.50

123

1058

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.85

0.73

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

277

0.72

0.73

4.1

3.7

41.42

26.87

mg/l

0.82

193

(3008401) Mugwort IgE Ab [Units/volume] in Serum

206

0.68

0.71

1.0

1.1

1.45

1.55

u/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

372

1.24

0.71

1.7

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

217

0.69

0.70

1.0

1.1

6.94

6.17

u/ml

—

113

(3023410) Appearance of Cerebral spinal fluid

152

1.39

0.69

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

402

1.23

0.67

1.6

1.4

11.63

8.29

u/l

0.92

319

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.58

0.65

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

243

1.28

0.63

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

243

1.28

0.63

1.1

—

(4281824) Cell count and differential, peritoneal fluid

121

1.41

0.62

1.4

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

183

1.32

0.59

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.53

0.59

2.0

1.6

—

1446899.86

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

162

0.68

0.58

1.1

1.4

33.35

26.22

u/l

0.25

133

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.58

0.0

1.6

—

0.51

—

(4024509) Urine culture

578

1.17

0.57

3.8

1.9

—

(44813793) Dust mix specific IgE antibody measurement

0.58

0.56

1.2

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.45

0.53

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

350

1.21

0.53

1.7

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

232

2166

1.08

0.52

1.6

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.50

0.51

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

161

1747

0.91

0.51

1.8

1.9

1.70

1.52

1.45

140

1516

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.39

0.50

1.6

1.3

21.79

27.04

umol/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.42

0.50

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

189

1.27

0.49

1.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.40

0.48

1.3

1.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1034

0.89

0.47

1.5

—

(4198724) Urine methamphetamine measurement

1.43

0.46

16.1

1.6

—

(3025130) Human papilloma virus identified in Specimen

138

1.31

0.45

1.6

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

138

1.31

0.45

1.6

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

570

5519

1.05

0.43

4.5

5.4

2.45

2.56

ug/l

0.10

526

5005

(40768793) Breast Pathology biopsy report

262

0.80

0.42

1.4

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

403

0.84

0.42

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

500

1.15

0.42

1.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.64

0.42

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.56

0.42

2.0

2.7

1703.40

113.34

ug/l

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.56

0.42

2.8

1.5

—

(3000492) Spirometry study

129

1398

0.92

0.42

1.4

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.43

0.41

1.1

—

(4015189) Microbial culture of sputum

1.52

0.41

5.8

2.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.52

0.41

1.8

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.5

—

36.73

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.41

0.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

78.22

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

303

0.82

0.40

1.6

1.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

4.7

—

48.93

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.39

0.38

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

1.35

0.38

2.7

2.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

135

1452

0.92

0.38

2.4

12.78

13.58

nmol/l

0.48

129

1321

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

320

3341

0.95

0.37

2.8

3.2

1.00

0.75

ug/l

2.48

247

2151

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.31

0.37

1.1

1.2

100.78

440.26

u/l

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.35

0.37

2.2

1.5

180.80

83.46

nmol/24h

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.35

0.37

1.0

1.1

—

(3010813) Leukocytes [#/volume] in Blood

1381

13908

0.93

0.36

69.0

24.6

7.20

6.75

e9/l

6.07

1366

13602

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.36

0.36

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

245

0.81

0.36

1.1

2.19

1.35

u/ml

—

129

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.64

0.35

1.4

1.9

—

(3000963) Hemoglobin [Mass/volume] in Blood

1381

13906

0.93

0.35

69.5

24.7

126.55

136.61

g/l

76.93

1373

13756

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

613

1.11

0.35

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.40

0.35

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.40

0.35

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.40

0.35

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.40

0.35

1.0

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1381

13903

0.93

0.34

71.1

25.1

38.41

41.33

9.01

1372

13748

(3026361) Erythrocytes [#/volume] in Blood

1381

13903

0.93

0.34

68.8

24.5

4.23

4.53

e12/l

57.47

1365

13603

(3035941) MCH [Entitic mass]

1381

13903

0.93

0.34

68.5

24.4

30.39

30.40

0.06

1373

13755

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1381

13900

0.93

0.32

68.6

24.5

92.30

91.13

16.32

1373

13754

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.28

0.32

1.5

2.9

18.55

203.15

ug/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

146

1.24

0.32

2.8

2.3

17.63

19.35

mg/l

—

(3007461) Platelets [#/volume] in Blood

1381

13896

0.94

0.30

68.9

24.5

243.76

246.20

e9/l

0.72

1367

13636

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.27

0.30

2.0

2.1

127.14

146.50

nmol/l

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

107

0.75

0.29

1.0

2.0

14.62

20.01

nmol/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

108

0.74

0.29

1.5

1.4

162.34

164.75

pmol/l

—

108

(40765096) Chromosome analysis panel by Banding

1.23

0.29

1.6

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

112

1.25

0.28

1.4

1.2

0.20

0.83

u/ml

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.20

0.26

1.5

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

137

1296

1.06

0.26

1.5

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.23

0.25

2.2

2.5

—

(1761868) Lipid panel - Serum or Plasma

527

5156

1.03

0.24

5.0

3.1

—

(3008898) HLA-B27 [Presence]

465

1.10

0.24

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

124

1.21

0.24

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.75

0.22

1.3

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.22

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

187.91

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

5.72

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.16

0.21

1.8

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.21

0.0

1.2

—

19.35

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

211

1.14

0.20

1.5

1.4

311.29

188.67

pmol/l

0.41

206

(3034274) Bile acid [Moles/volume] in Serum --fasting

117

1.20

0.20

1.4

2.4

6.21

7.81

umol/l

0.24

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.23

0.20

1.0

1.8

2.27

1.96

umol/l

—

(4211845) Urine protein measurement

1.18

0.19

4.7

3.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

120

1146

1.05

0.18

1.6

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

609

1.07

0.18

1.9

2.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1184

11759

1.03

0.18

5.8

5.1

2.03

1.92

mu/l

1.54

1134

10872

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.76

0.17

1.2

15.40

9.39

mm/h

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.73

0.17

11.2

8.0

—

66.37

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

162

0.86

0.16

1.8

1.6

—

(3016879) Cocaine [Presence] in Urine

463

0.93

0.16

3.0

2.3

—

(44806420) Estimation of glomerular filtration rate

130

1.16

0.15

3.1

2.5

—

(3006653) Thiamine [Moles/volume] in Blood

1.21

0.15

1.4

1.3

132.20

144.26

nmol/l

—

(3028707) Methadone [Presence] in Urine by Screen method

217

1.11

0.14

6.3

3.0

—

(1002224) Polysomnography panel

692

1.04

0.10

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.15

0.10

2.5

1.4

105.55

84.75

umol/l

0.75

(3028300) Cannabinoids [Presence] in Urine

504

0.95

0.10

3.9

2.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.07

0.08

1.0

1.7

—

0.71

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.03

0.08

5.0

2.0

—

(3027008) Opiates [Presence] in Urine

501

0.96

0.08

3.8

2.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

1.06

0.08

1.0

1.6

25.14

29.76

umol/l

—

(3000764) Benzodiazepines [Presence] in Urine

500

0.96

0.07

3.8

2.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1.12

0.07

1.2

1.0

490.73

628.05

ng/l

1.28

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.12

0.07

1.2

1.0

48.95

37.81

ng/l

0.32

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1.12

0.07

1.2

1.0

393.82

279.80

ng/l

0.64

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.86

0.07

1.3

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

0.87

0.07

1.0

1.3

—

56.25

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.87

0.06

2.4

2.0

—

(3011288) Drugs identified in Urine by Screen method Nominal

346

0.95

0.06

5.1

3.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

295

1.05

0.06

2.6

3.5

66.37

295.23

u/ml

1.49

275

(3027944) Amphetamines [Presence] in Urine

497

0.96

0.06

3.8

2.1

—

(36660697) Celiac disease serology panel - Serum

103

1010

1.02

0.05

1.3

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

190

1.05

0.04

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

129

0.93

0.03

1.3

1.7

261.43

325.00

mu/l

0.89

102

(3005570) Glucose [Moles/volume] in Urine

139

0.93

0.03

2.1

1.8

—

(4034850) Laboratory test

401

0.97

0.03

15.5

10.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

161

1.06

0.03

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

147

1485

0.99

0.03

16.1

7.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

126

1250

1.01

0.01

1.6

2.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

839

0.99

0.01

1.2

66.66

140.63

u/ml

2.29

332

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

146

0.96

0.00

1.3

8.00

7.68

mmol/l

0.18

127

(1001926) Buprenorphine [Presence] in Urine by Screen method

386

0.98

0.00

4.4

2.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

114

0.96

0.00

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

334

0.99

0.00

1.4

2.0

1.98

4.23

iu/l

3.66

137

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

118

1.02

0.00

1.6

85.53

56.41

ug/l

0.56

118

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

548

1.00

0.00

1.9

38.37

39.22

nmol/l

0.09

526

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

209

1.00

0.00

1.6

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.96

0.00

1.4

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

-0.00

0.0

1.2

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

550

1.00

-0.00

1.5

1.4

27.14

27.75

iu/l

0.04

464

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

413.89

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

98.14

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

522.00

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1745.20

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

2.28

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

305.25

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.8

—

2.87

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.97

-0.00

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

2.88

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.7

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

0.94

-0.00

2.8

1.9

1.38

4.98

nmol/l

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

0.03

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_CHRONEPHROPATH and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_CHRONEPHROPATH	2.953 [2.51, 3.47]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.075

During the follow-up period (1.1.1998 — 31.12.2019), 650 out of 2317 females with N14_CHRONEPHROPATH died.

Males

Parameter	HR [95% CI]	p-value
N14_CHRONEPHROPATH	2.713 [2.41, 3.06]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 1145 out of 3091 males with N14_CHRONEPHROPATH died.

Mortality risk

Mortality risk for people of age

years, who have N14_CHRONEPHROPATH.

N-year risk	Females	Males
1	0.326%	0.519%
5	1.781%	3.095%
10	4.435%	7.277%
15	8.103%	13.566%
20	13.509%	22.233%

Relationships between endpoints

↥

Index endpoint: N14_CHRONEPHROPATH – Chronic nephritic syndrome

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Chronic nephritic syndrome

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints